(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
, | | |||||||||||||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||||||||||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||||
☒ | Smaller reporting company | ||||||||||
Emerging growth company |
March 31, 2022 | December 31, 2021* | ||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Cash and due from banks | $ | $ | |||||||||||||||||||||
Interest-bearing deposits at other financial institutions | |||||||||||||||||||||||
Securities held-to-maturity (fair value of $ | |||||||||||||||||||||||
Securities available-for-sale, at fair value | |||||||||||||||||||||||
Restricted stock, at cost | |||||||||||||||||||||||
Loans, net of allowance for loan losses of $ | |||||||||||||||||||||||
Premises and equipment, net | |||||||||||||||||||||||
Accrued interest receivable | |||||||||||||||||||||||
Prepaid expenses | |||||||||||||||||||||||
Deferred tax assets, net | |||||||||||||||||||||||
Goodwill and intangibles, net | |||||||||||||||||||||||
Bank owned life insurance (BOLI) | |||||||||||||||||||||||
Operating lease right-of-use assets | |||||||||||||||||||||||
Other assets | |||||||||||||||||||||||
Total assets | $ | $ | |||||||||||||||||||||
Liabilities and Stockholders' Equity | |||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Deposits: | |||||||||||||||||||||||
Noninterest-bearing | $ | $ | |||||||||||||||||||||
Interest-bearing checking, savings and money market | |||||||||||||||||||||||
Time deposits | |||||||||||||||||||||||
Total deposits | $ | $ | |||||||||||||||||||||
FHLB advances | $ | $ | |||||||||||||||||||||
Subordinated notes, net of issuance costs | |||||||||||||||||||||||
Accrued interest payable | |||||||||||||||||||||||
Operating lease liabilities | |||||||||||||||||||||||
Accrued expenses and other liabilities | |||||||||||||||||||||||
Total liabilities | $ | $ | |||||||||||||||||||||
Commitments and Contingent Liabilities | |||||||||||||||||||||||
Stockholders' Equity | 2022 | 2021 | |||||||||||||||||||||
Preferred stock, $ | |||||||||||||||||||||||
Shares authorized | |||||||||||||||||||||||
Shares issued and outstanding | $ | $ | |||||||||||||||||||||
Common stock, $ | |||||||||||||||||||||||
Shares authorized | |||||||||||||||||||||||
Shares issued and outstanding | |||||||||||||||||||||||
Additional paid-in capital | |||||||||||||||||||||||
Retained earnings | |||||||||||||||||||||||
Accumulated other comprehensive (loss), net | ( | ( | |||||||||||||||||||||
Total stockholders' equity | $ | $ | |||||||||||||||||||||
Total liabilities and stockholders' equity | $ | $ |
For the three months ended | |||||||||||
March 31, | |||||||||||
2022 | 2021 | ||||||||||
Interest and Dividend Income | |||||||||||
Interest and fees on loans | $ | $ | |||||||||
Interest and dividends on securities held-to-maturity | |||||||||||
Interest and dividends on securities available-for-sale | |||||||||||
Dividends on restricted stock | |||||||||||
Interest on deposits at other financial institutions | |||||||||||
Total interest and dividend income | $ | $ | |||||||||
Interest Expense | |||||||||||
Interest on deposits | $ | $ | |||||||||
Interest on short-term debt | |||||||||||
Interest on subordinated notes | |||||||||||
Total interest expense | $ | $ | |||||||||
Net Interest Income | $ | $ | |||||||||
Provision for loan losses | |||||||||||
Net interest income after provision for loan losses | $ | $ | |||||||||
Noninterest Income | |||||||||||
Service charges on deposit accounts | $ | $ | |||||||||
BOLI income | |||||||||||
Income from minority membership interest | |||||||||||
Other income | |||||||||||
Total noninterest income | $ | $ | |||||||||
Noninterest Expenses | |||||||||||
Salaries and employee benefits | $ | $ | |||||||||
Occupancy and equipment expense | |||||||||||
Data processing and network administration | |||||||||||
State franchise taxes | |||||||||||
Audit, legal and consulting fees | |||||||||||
Merger and acquisition expense | |||||||||||
Loan related expenses | |||||||||||
FDIC insurance | |||||||||||
Marketing, business development and advertising | |||||||||||
Director fees | |||||||||||
Postage, courier and telephone | |||||||||||
Internet banking | |||||||||||
Core deposit intangible amortization | |||||||||||
Other operating expenses | |||||||||||
Total noninterest expenses | $ | $ | |||||||||
Net income before income tax expense | $ | $ | |||||||||
Income tax expense | |||||||||||
Net income | $ | $ | |||||||||
Earnings per share, basic | $ | $ | |||||||||
Earnings per share, diluted | $ | $ |
March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
Net income | $ | $ | ||||||||||||
Other comprehensive (loss): | ||||||||||||||
Unrealized loss on securities available for sale, net of tax benefit of $ | ( | ( | ||||||||||||
Unrealized gain on interest rate swaps, net of tax expense of $ | ||||||||||||||
Total other comprehensive loss | $ | ( | $ | ( | ||||||||||
Total comprehensive (loss) income | $ | ( | $ |
2022 | 2021 | ||||||||||
Cash Flows From Operating Activities | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation | |||||||||||
Provision for loan losses | |||||||||||
Net amortization of premium of securities | |||||||||||
Net amortization of deferred loan costs and purchase premiums | ( | ( | |||||||||
Net accretion of acquisition accounting adjustments | ( | ( | |||||||||
Income from minority membership interest | ( | ||||||||||
Amortization of subordinated debt issuance costs | |||||||||||
Core deposits intangible amortization | |||||||||||
Stock-based compensation expense | |||||||||||
BOLI income | ( | ( | |||||||||
Changes in assets and liabilities: | |||||||||||
(Increase) decrease in accrued interest receivable, prepaid expenses and other assets | ( | ||||||||||
Increase (decrease) in accrued interest payable, accrued expenses and other liabilities | ( | ||||||||||
Net cash provided by operating activities | $ | $ | |||||||||
Cash Flows From Investing Activities | |||||||||||
Decrease (increase) in interest-bearing deposits at other financial institutions | $ | $ | ( | ||||||||
Purchases of securities available-for-sale | ( | ( | |||||||||
Proceeds from maturities and calls of securities available-for-sale | |||||||||||
Proceeds from redemptions of securities available-for-sale | |||||||||||
Net redemption of restricted stock | |||||||||||
Net (increase) decrease in loans | ( | ||||||||||
Distribution received from minority owned investment | |||||||||||
Purchases of premises and equipment, net | ( | ( | |||||||||
Net cash provided by (used in) investing activities | $ | $ | ( | ||||||||
Cash Flows From Financing Activities | |||||||||||
Net (decrease) increase in noninterest-bearing, interest-bearing checking, savings, and money market deposits | $ | ( | $ | ||||||||
Net decrease in time deposits | ( | ( | |||||||||
Common stock issuance | |||||||||||
Net cash (used in) provided by financing activities | $ | ( | $ | ||||||||
Net decrease in cash and cash equivalents | $ | ( | $ | ( | |||||||
Cash and cash equivalents, beginning of year | |||||||||||
Cash and cash equivalents, end of period | $ | $ |
Shares | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total | ||||||||||||||||||||||||||||||
Balance at December 31, 2020 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Net income | — | — | — | — | |||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
Common stock issuance for options exercised, net | — | — | |||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | |||||||||||||||||||||||||||||||
Balance at March 31, 2021 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
Balance at December 31, 2021 | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||
Net income | — | — | — | — | |||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||
Common stock issuance for options exercised, net | — | — | |||||||||||||||||||||||||||||||||
Vesting of restricted stock grants | — | — | — | — | — | ||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | |||||||||||||||||||||||||||||||
Balance at March 31, 2022 | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||
March 31, 2022 | ||||||||||||||||||||||||||
(In thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized (Losses) | Fair Value | ||||||||||||||||||||||
Held-to-maturity | ||||||||||||||||||||||||||
Securities of state and local municipalities tax exempt | $ | $ | $ | $ | ||||||||||||||||||||||
Total Held-to-maturity Securities | $ | $ | $ | $ | ||||||||||||||||||||||
Available-for-sale | ||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | $ | $ | $ | ( | $ | |||||||||||||||||||||
Securities of state and local municipalities tax exempt | ||||||||||||||||||||||||||
Securities of state and local municipalities taxable | ( | |||||||||||||||||||||||||
Corporate bonds | ( | |||||||||||||||||||||||||
SBA pass-through securities | ( | |||||||||||||||||||||||||
Mortgage-backed securities | ( | |||||||||||||||||||||||||
Collateralized mortgage obligations | ( | |||||||||||||||||||||||||
Total Available-for-sale Securities | $ | $ | $ | ( | $ |
December 31, 2021 | ||||||||||||||||||||||||||
(In thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized (Losses) | Fair Value | ||||||||||||||||||||||
Held-to-maturity | ||||||||||||||||||||||||||
Securities of state and local municipalities tax exempt | $ | $ | $ | $ | ||||||||||||||||||||||
Total Held-to-maturity Securities | $ | $ | $ | $ | ||||||||||||||||||||||
Available-for-sale | ||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | $ | $ | $ | ( | $ | |||||||||||||||||||||
Securities of state and local municipalities tax exempt | ||||||||||||||||||||||||||
Securities of state and local municipalities taxable | ( | |||||||||||||||||||||||||
Corporate bonds | ( | |||||||||||||||||||||||||
SBA pass-through securities | ||||||||||||||||||||||||||
Mortgage-backed securities | ( | |||||||||||||||||||||||||
Collateralized mortgage obligations | ( | |||||||||||||||||||||||||
Total Available-for-sale Securities | $ | $ | $ | ( | $ |
Less Than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||||||||
At March 31, 2022 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | ||||||||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | $ | $ | ( | $ | $ | $ | $ | ( | ||||||||||||||||||||||||||||||
Securities of state and local municipalities taxable | ( | ( | ||||||||||||||||||||||||||||||||||||
Corporate bonds | ( | ( | ||||||||||||||||||||||||||||||||||||
SBA pass-through securities | ( | ( | ||||||||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Collateralized mortgage obligations | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | $ | ( | $ | $ | ( |
Less Than 12 Months | 12 Months or Longer | Total | ||||||||||||||||||||||||||||||||||||
At December 31, 2021 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | ||||||||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | $ | $ | ( | $ | $ | $ | $ | ( | ||||||||||||||||||||||||||||||
Securities of state and local municipalities taxable | ( | ( | ||||||||||||||||||||||||||||||||||||
Corporate bonds | $ | $ | ( | $ | $ | $ | $ | ( | ||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Collateralized mortgage obligations | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | $ | ( | $ | $ | ( |
March 31, 2022 | ||||||||||||||||||||||||||
Held-to-maturity | Available-for-sale | |||||||||||||||||||||||||
(In thousands) | Amortized Cost | Fair Value | Amortized Cost | Fair Value | ||||||||||||||||||||||
After 1 year through 5 years | $ | $ | $ | $ | ||||||||||||||||||||||
After 5 years through 10 years | ||||||||||||||||||||||||||
After 10 years | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
March 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||
(In thousands) | Originated | Acquired | Total | Originated | Acquired | Total | ||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||
Less: | ||||||||||||||||||||||||||||||||||||||
Allowance for loan losses | ||||||||||||||||||||||||||||||||||||||
Unearned income and (unamortized premiums), net | ||||||||||||||||||||||||||||||||||||||
Loans, net | $ | $ | $ | $ | $ | $ |
(In thousands) | March 31, 2022 | |||||||
Purchased credit impaired acquired loans evaluated individually for credit losses | ||||||||
Outstanding principal balance | $ | |||||||
Carrying amount | ||||||||
Other acquired loans | ||||||||
Outstanding principal balance | ||||||||
Carrying amount | ||||||||
Total acquired loans | ||||||||
Outstanding principal balance | ||||||||
Carrying amount |
(In thousands) | December 31, 2021 | |||||||
Purchased credit impaired acquired loans evaluated individually for credit losses | ||||||||
Outstanding principal balance | $ | |||||||
Carrying amount | ||||||||
Other acquired loans | ||||||||
Outstanding principal balance | ||||||||
Carrying amount | ||||||||
Total acquired loans | ||||||||
Outstanding principal balance | ||||||||
Carrying amount |
(In thousands) | ||||||||
Balance at January 1, 2022 | $ | |||||||
Accretion | ( | |||||||
Reclassification of nonaccretable difference due to changes in expected cash flows | ||||||||
Other changes, net | ||||||||
Balance at March 31, 2022 | $ | |||||||
(In thousands) | ||||||||
Balance at January 1, 2021 | $ | |||||||
Accretion | ( | |||||||
Reclassification of nonaccretable difference due to changes in expected cash flows | ||||||||
Other changes, net | ( | |||||||
Balance at December 31, 2021 | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Allowance for credit losses: | ||||||||||||||||||||||||||||||||||||||
Beginning Balance, January 1 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Charge-offs | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Recoveries | ||||||||||||||||||||||||||||||||||||||
Provision | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Ending Balance | $ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Allowance for credit losses: | ||||||||||||||||||||||||||||||||||||||
Beginning Balance, January 1 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Charge-offs | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Recoveries | ||||||||||||||||||||||||||||||||||||||
Provision | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Ending Balance | $ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Allowance for credit losses: | ||||||||||||||||||||||||||||||||||||||
Beginning Balance, January 1 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Charge-offs | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||
Recoveries | ||||||||||||||||||||||||||||||||||||||
Provision | ( | ( | ( | |||||||||||||||||||||||||||||||||||
Ending Balance | $ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Allowance for credit losses: | ||||||||||||||||||||||||||||||||||||||
Ending Balance | ||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Purchased credit impaired | ||||||||||||||||||||||||||||||||||||||
Collectively evaluated for impairment | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Financing receivables: | ||||||||||||||||||||||||||||||||||||||
Ending Balance | ||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Purchased credit impaired | ||||||||||||||||||||||||||||||||||||||
Collectively evaluated for impairment | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Allowance for credit losses: | ||||||||||||||||||||||||||||||||||||||
Ending Balance | ||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Purchased credit impaired | ||||||||||||||||||||||||||||||||||||||
Collectively evaluated for impairment | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Financing receivables: | ||||||||||||||||||||||||||||||||||||||
Ending Balance | ||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Purchased credit impaired | ||||||||||||||||||||||||||||||||||||||
Collectively evaluated for impairment | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Allowance for credit losses: | ||||||||||||||||||||||||||||||||||||||
Ending Balance | ||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Purchased credit impaired | ||||||||||||||||||||||||||||||||||||||
Collectively evaluated for impairment | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ |
Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | |||||||||||||||||||||||||||||||||
Financing receivables: | ||||||||||||||||||||||||||||||||||||||
Ending Balance | ||||||||||||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Purchased credit impaired | ||||||||||||||||||||||||||||||||||||||
Collectively evaluated for impairment | ||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ |
(In thousands) | Recorded Investment | Unpaid Principal Balance | Related Allowance | Average Recorded Investment | Interest Income Recognized | |||||||||||||||||||||||||||
March 31, 2022 | ||||||||||||||||||||||||||||||||
With an allowance recorded: | ||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | ||||||||||||||||||||||||||||
March 31, 2022 | ||||||||||||||||||||||||||||||||
With no related allowance: | ||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | — | $ | $ | ||||||||||||||||||||||||||
Commercial and industrial | — | |||||||||||||||||||||||||||||||
Commercial construction | — | |||||||||||||||||||||||||||||||
Consumer real estate | — | |||||||||||||||||||||||||||||||
Consumer nonresidential | — | |||||||||||||||||||||||||||||||
$ | $ | $ | — | $ | $ |
(In thousands) | Recorded Investment | Unpaid Principal Balance | Related Allowance | Average Recorded Investment | Interest Income Recognized | |||||||||||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||||||||||
With an allowance recorded: | ||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | ||||||||||||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||||||||||
With no related allowance: | ||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | — | $ | $ | ||||||||||||||||||||||||||
Commercial and industrial | — | |||||||||||||||||||||||||||||||
Commercial construction | — | |||||||||||||||||||||||||||||||
Consumer real estate | — | |||||||||||||||||||||||||||||||
Consumer nonresidential | — | |||||||||||||||||||||||||||||||
$ | $ | $ | — | $ | $ |
(In thousands) | Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | ||||||||||||||||||||||||||||||||
Grade: | ||||||||||||||||||||||||||||||||||||||
Pass | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Special mention | ||||||||||||||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||||||||||||||
Doubtful | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Loss | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
(In thousands) | Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | ||||||||||||||||||||||||||||||||
Grade: | ||||||||||||||||||||||||||||||||||||||
Pass | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Special mention | ||||||||||||||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||||||||||||||
Doubtful | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Loss | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
(In thousands) | Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | ||||||||||||||||||||||||||||||||
Grade: | ||||||||||||||||||||||||||||||||||||||
Pass | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Special mention | ||||||||||||||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||||||||||||||
Doubtful | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Loss | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
(In thousands) | Commercial Real Estate | Commercial and Industrial | Commercial Construction | Consumer Real Estate | Consumer Nonresidential | Total | ||||||||||||||||||||||||||||||||
Grade: | ||||||||||||||||||||||||||||||||||||||
Pass | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
Special mention | ||||||||||||||||||||||||||||||||||||||
Substandard | ||||||||||||||||||||||||||||||||||||||
Doubtful | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Loss | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
(In thousands) | 30-59 days past due | 60-89 days past due | 90 days or more past due | Total past due | Current | Total loans | 90 days past due and still accruing | Nonaccruals | ||||||||||||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
(In thousands) | 30-59 days past due | 60-89 days past due | 90 or more past due | Total past due | Current | Total loans | 90 days past due and still accruing | Nonaccruals | ||||||||||||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
(In thousands) | 30-59 days past due | 60-89 days past due | 90 or more past due | Total past due | Current | Total loans | 90 days past due and still accruing | Nonaccruals | ||||||||||||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
(In thousands) | 30-59 days past due | 60-89 days past due | 90 or more past due | Total past due | Current | Total loans | 90 days past due and still accruing | Nonaccruals | ||||||||||||||||||||||||||||||||||||||||||
Commercial real estate | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Commercial and industrial | ||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial construction | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer real estate | ||||||||||||||||||||||||||||||||||||||||||||||||||
Consumer nonresidential | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | $ |
Troubled Debt Restructurings | Number of Contracts | Pre-Modification Outstanding Recorded Investment | Post-Modification Outstanding Recorded Investment | |||||||||||||||||
(Dollars in thousands) | ||||||||||||||||||||
Consumer real estate | $ | $ | ||||||||||||||||||
Total | $ | $ |
March 31, 2022 | ||||||||||||||
Notional Amount | Fair Value | |||||||||||||
(In thousands) | ||||||||||||||
Interest Rate Swap Agreements | ||||||||||||||
Receive Fixed/Pay Variable Swaps | $ | $ | ||||||||||||
Pay Fixed/Receive Variable Swaps | ( |
December 31, 2021 | ||||||||||||||
Notional Amount | Fair Value | |||||||||||||
(In thousands) | ||||||||||||||
Interest Rate Swap Agreements | ||||||||||||||
Receive Fixed/Pay Variable Swaps | $ | $ | ||||||||||||
Pay Fixed/Receive Variable Swaps | ( |
(Dollars in thousands) | March 31, 2022 | December 31, 2021 | ||||||||||||
Notional amount | $ | $ | ||||||||||||
Weighted average pay rate | % | % | ||||||||||||
Weighted average receive rate | % | % | ||||||||||||
Weighted average maturity in years | ||||||||||||||
Unrealized gain (loss) relating to interest rate swaps | $ | $ | ( |
(In thousands) | March 31, 2022 | December 31, 2021 | ||||||||||||
Commitments to grant loans | $ | $ | ||||||||||||
Unused commitments to fund loans and lines of credit | ||||||||||||||
Commercial and standby letters of credit | ||||||||||||||
Interest rate lock commitments |
Options | Number of Shares | Weighted- Average Exercise Price | Weighted- Average Contractual Remaining Term (Years) | Aggregate Intrinsic Value (1) | ||||||||||||||||||||||
Outstanding at January 1, 2022 | $ | |||||||||||||||||||||||||
Granted | ||||||||||||||||||||||||||
Exercised | ( | |||||||||||||||||||||||||
Forfeited or expired | ( | |||||||||||||||||||||||||
Outstanding and Exercisable at March 31, 2022 | $ | $ |
Number of Shares | Weighted Average Grant Date Fair Value | |||||||||||||
Nonvested at January 1, 2022 | $ | |||||||||||||
Granted | ||||||||||||||
Vested | ( | |||||||||||||
Forfeited | ( | |||||||||||||
Balance at March 31, 2022 | $ |
Level 1 — | Valuation is based on quoted prices in active markets for identical assets and liabilities. | ||||
Level 2 — | Valuation is based on observable inputs including quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets and liabilities in less active markets, and model-based valuation techniques for which significant assumptions can be derived primarily from or corroborated by observable data in the market. | ||||
Level 3 — | Valuation is based on model-based techniques that use one or more significant inputs or assumptions that are unobservable in the market. |
Fair Value Measurements at March 31, 2022 Using | ||||||||||||||||||||||||||
(In thousands) | Balance as of March 31, 2022 | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | ||||||||||||||||||||||
Description | (Level 1) | (Level 2) | (Level 3) | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Available-for-sale | ||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | $ | $ | $ | $ | ||||||||||||||||||||||
Securities of state and local municipalities tax exempt | ||||||||||||||||||||||||||
Securities of state and local municipalities taxable | ||||||||||||||||||||||||||
Corporate bonds | ||||||||||||||||||||||||||
SBA pass-through securities | ||||||||||||||||||||||||||
Mortgage-backed securities | ||||||||||||||||||||||||||
Collateralized mortgage obligations | ||||||||||||||||||||||||||
Total Available-for-Sale Securities | $ | $ | $ | $ |
Fair Value Measurements at December 31, 2021 Using | ||||||||||||||||||||||||||
(In thousands) | Balance as of December 31, 2021 | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | ||||||||||||||||||||||
Description | (Level 1) | (Level 2) | (Level 3) | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Available-for-sale | ||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | $ | $ | $ | $ | ||||||||||||||||||||||
Securities of state and local municipalities tax exempt | ||||||||||||||||||||||||||
Securities of state and local municipalities taxable | ||||||||||||||||||||||||||
Corporate bonds | ||||||||||||||||||||||||||
SBA pass-through securities | ||||||||||||||||||||||||||
Mortgage-backed securities | ||||||||||||||||||||||||||
Collateralized mortgage obligations | ||||||||||||||||||||||||||
Total Available-for-Sale Securities | $ | $ | $ | $ |
Fair Value Measurements Using | ||||||||||||||||||||||||||
(In thousands) | Balance as of March 31, 2022 | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | ||||||||||||||||||||||
Description | (Level 1) | (Level 2) | (Level 3) | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Impaired loans | ||||||||||||||||||||||||||
Commercial and industrial | $ | $ | $ | $ | ||||||||||||||||||||||
Consumer residential | ||||||||||||||||||||||||||
Total Impaired loans | $ | $ | $ | $ |
Fair Value Measurements Using | ||||||||||||||||||||||||||
(In thousands) | Balance as of December 31, 2021 | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | ||||||||||||||||||||||
Description | (Level 1) | (Level 2) | (Level 3) | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Impaired loans | ||||||||||||||||||||||||||
Commercial and industrial | $ | $ | $ | $ | ||||||||||||||||||||||
Consumer residential | ||||||||||||||||||||||||||
Total Impaired loans | $ | $ | $ | $ |
Quantitative information about Level 3 Fair Value Measurements for March 31, 2022 | ||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Assets | Fair Value | Valuation Technique(s) | Unobservable input | Range | (Avg.) | |||||||||||||||||||||||||||
Impaired loans | ||||||||||||||||||||||||||||||||
Commercial and industrial | $ | Discounted appraised value | Marketability/Selling costs | % | ||||||||||||||||||||||||||||
Consumer residential | Discounted appraised value | Marketability/Selling costs | % | |||||||||||||||||||||||||||||
Total impaired loans | $ | Discounted appraised value | Marketability/Selling costs | % |
Quantitative information about Level 3 Fair Value Measurements for December 31, 2021 | ||||||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Assets | Fair Value | Valuation Technique(s) | Unobservable input | Range | (Avg.) | |||||||||||||||||||||||||||
Impaired loans | ||||||||||||||||||||||||||||||||
Commercial and industrial | $ | Discounted appraised value | Marketability/Selling costs | % | ||||||||||||||||||||||||||||
Consumer residential | Discounted appraised value | Marketability/Selling costs | % | |||||||||||||||||||||||||||||
Total impaired loans | $ | Discounted appraised value | Marketability/Selling costs | % |
Fair Value Measurements as of March 31, 2022, using | ||||||||||||||||||||||||||
Carrying Amount | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |||||||||||||||||||||||
(In thousands) | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||
Financial assets: | ||||||||||||||||||||||||||
Cash and due from banks | $ | $ | $ | $ | ||||||||||||||||||||||
Interest-bearing deposits at other institutions | ||||||||||||||||||||||||||
Securities held-to-maturity | ||||||||||||||||||||||||||
Securities available-for-sale | ||||||||||||||||||||||||||
Restricted stock | ||||||||||||||||||||||||||
Loans, net | ||||||||||||||||||||||||||
Derivative assets - interest rate swaps | ||||||||||||||||||||||||||
Derivative assets - cash flow hedge | ||||||||||||||||||||||||||
Bank owned life insurance | ||||||||||||||||||||||||||
Accrued interest receivable | ||||||||||||||||||||||||||
Financial liabilities: | ||||||||||||||||||||||||||
Checking, savings and money market accounts | $ | $ | $ | $ | ||||||||||||||||||||||
Time deposits | ||||||||||||||||||||||||||
FHLB advances | ||||||||||||||||||||||||||
Subordinated notes | ||||||||||||||||||||||||||
Accrued interest payable | ||||||||||||||||||||||||||
Derivative liabilties - interest rate swaps | ||||||||||||||||||||||||||
Derivative liabilties - cash flow hedge |
Fair Value Measurements as of December 31, 2021, using | ||||||||||||||||||||||||||
Carrying Amount | Quoted Prices in Active Markets for Identical Assets | Significant Other Observable Inputs | Significant Unobservable Inputs | |||||||||||||||||||||||
(In thousands) | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||
Financial assets: | ||||||||||||||||||||||||||
Cash and due from banks | $ | $ | $ | $ | ||||||||||||||||||||||
Interest-bearing deposits at other institutions | ||||||||||||||||||||||||||
Securities held-to-maturity | ||||||||||||||||||||||||||
Securities available-for-sale | ||||||||||||||||||||||||||
Restricted stock | ||||||||||||||||||||||||||
Loans, net | ||||||||||||||||||||||||||
Derivative assets - interest rate swaps | ||||||||||||||||||||||||||
Bank owned life insurance | ||||||||||||||||||||||||||
Accrued interest receivable | ||||||||||||||||||||||||||
Financial liabilities: | ||||||||||||||||||||||||||
Checking, savings and money market accounts | $ | $ | $ | $ | ||||||||||||||||||||||
Time deposits | ||||||||||||||||||||||||||
FHLB advances | ||||||||||||||||||||||||||
Subordinated notes | ||||||||||||||||||||||||||
Accrued interest payable | ||||||||||||||||||||||||||
Derivative liabilties - interest rate swaps | ||||||||||||||||||||||||||
Derivative liabilties - cash flow hedge |
Three Months Ended March 31, | |||||||||||||||||
(In thousands, except per share data) | 2022 | 2021 | |||||||||||||||
Net income | $ | $ | |||||||||||||||
Weighted average number of shares | |||||||||||||||||
Effect of dilutive securities, restricted stock units and options | |||||||||||||||||
Weighted average diluted shares | |||||||||||||||||
Basic EPS | $ | $ | |||||||||||||||
Diluted EPS | $ | $ |
(In thousands) | ||||||||||||||||||||
Three Months Ended March 31, 2022 | Available-for-Sale Securities | Cash Flow Hedges | Total | |||||||||||||||||
Balance, beginning of period | $ | ( | $ | ( | $ | ( | ||||||||||||||
Net unrealized (losses) gains during the period | ( | ( | ||||||||||||||||||
Other comprehensive (loss) income, net of tax | ( | ( | ||||||||||||||||||
Balance, end of period | $ | ( | $ | $ | ( |
(In thousands) | ||||||||||||||||||||
Three Months Ended March 31, 2021 | Available-for-Sale Securities | Cash Flow Hedges | Total | |||||||||||||||||
Balance, beginning of period | $ | $ | ( | $ | ||||||||||||||||
Net unrealized (losses) gains during the period | ( | ( | ||||||||||||||||||
Other comprehensive (loss) income, net of tax | ( | ( | ||||||||||||||||||
Balance, end of period | $ | $ | ( | $ |
Three Months Ended March 31, | |||||||||||||||||
(In thousands) | 2022 | 2021 | |||||||||||||||
Noninterest Income | |||||||||||||||||
In-scope of Topic 606 | |||||||||||||||||
Service Charges on Deposit Accounts | $ | $ | |||||||||||||||
Fees, Exchange, and Other Service Charges | |||||||||||||||||
Other income | |||||||||||||||||
Noninterest Income (in-scope of Topic 606) | |||||||||||||||||
Noninterest Income (out-scope of Topic 606) | |||||||||||||||||
Total Noninterest Income | $ | $ |
For the Three Months Ended March 31, | ||||||||||||||
(In thousands) | 2022 | 2021 | ||||||||||||
Supplemental Disclosure of Cash Flow Information: | ||||||||||||||
Cash paid for: | ||||||||||||||
Interest on deposits and borrowed funds | $ | $ | ||||||||||||
Income taxes | ||||||||||||||
Noncash investing and financing activities: | ||||||||||||||
Unrealized (loss) gain on securities available-for-sale | ( | ( | ||||||||||||
Unrealized gain (loss) on interest rate swaps | ||||||||||||||
2022 | 2021 | |||||||||||||
Net income (as reported) | $ | 6,613 | $ | 5,569 | ||||||||||
Add: merger and acquisition expense | 125 | — | ||||||||||||
Less: provision for income taxes associated with impairment and merger and acquisition expense | (28) | — | ||||||||||||
Non-GAAP Operating Earnings, excluding above items | $ | 6,710 | $ | 5,569 | ||||||||||
Earnings per share - basic (GAAP net income) | 0.48 | 0.41 | ||||||||||||
Earnings per share - Non-GAAP expenses including provision for income taxes | 0.01 | — | ||||||||||||
Earnings per share - basic (non-GAAP net income) | $ | 0.49 | $ | 0.41 | ||||||||||
Earnings per share - diluted (GAAP net income) | $ | 0.45 | $ | 0.38 | ||||||||||
Earnings per share - Non-GAAP expenses including provision for income taxes | 0.01 | — | ||||||||||||
Earnings per share - diluted (non-GAAP net income) | $ | 0.46 | $ | 0.38 | ||||||||||
Return on average assets (GAAP net income) | 1.30 | % | 1.19 | % | ||||||||||
Non-GAAP expenses including provision for income taxes | 0.02 | % | — | % | ||||||||||
Return on average assets (non‑GAAP net income) | 1.32 | % | 1.19 | % | ||||||||||
Return on average equity (GAAP net income) | 12.63 | % | 11.53 | % | ||||||||||
Non-GAAP expenses including provision for income taxes | 0.18 | % | — | % | ||||||||||
Return on average equity (non‑GAAP net income) | 12.81 | % | 11.53 | % |
2022 | 2021 | ||||||||||||||||||||||||||||||||||
Average Balance | Interest Income/Expense | Average Yield/ Rate | Average Balance | Interest Income/Expense | Average Yield/ Rate | ||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||
Interest-earning assets: | |||||||||||||||||||||||||||||||||||
Loans (1): | |||||||||||||||||||||||||||||||||||
Commercial real estate | $ | 914,106 | $ | 9,428 | 4.13 | % | $ | 782,639 | $ | 8,396 | 4.29 | % | |||||||||||||||||||||||
Commercial and industrial | 175,881 | 1,844 | 4.19 | % | 111,360 | 1,344 | 4.83 | % | |||||||||||||||||||||||||||
Paycheck protection program | 19,421 | 285 | 5.87 | % | 162,066 | 1,832 | 4.52 | % | |||||||||||||||||||||||||||
Commercial construction | 180,388 | 2,149 | 4.76 | % | 220,835 | 2,427 | 4.40 | % | |||||||||||||||||||||||||||
Consumer residential | 175,207 | 1,733 | 3.96 | % | 165,211 | 1,676 | 4.06 | % | |||||||||||||||||||||||||||
Consumer nonresidential | 9,335 | 168 | 7.18 | % | 14,199 | 258 | 7.27 | % | |||||||||||||||||||||||||||
Total loans (1) | 1,474,338 | 15,607 | 4.23 | % | 1,456,310 | 15,933 | 4.38 | % | |||||||||||||||||||||||||||
Investment securities (2) | 351,318 | 1,491 | 1.70 | % | 122,585 | 724 | 2.36 | % | |||||||||||||||||||||||||||
Restricted stock | 6,157 | 82 | 5.32 | % | 6,403 | 82 | 5.12 | % | |||||||||||||||||||||||||||
Deposits at other financial institutions and federal funds sold | 108,224 | 45 | 0.17 | % | 182,891 | 45 | 0.10 | % | |||||||||||||||||||||||||||
Total interest-earning assets and interest income | 1,940,037 | 17,225 | 3.55 | % | 1,768,189 | 16,784 | 3.80 | % | |||||||||||||||||||||||||||
Noninterest-earning assets: | |||||||||||||||||||||||||||||||||||
Cash and due from banks | 10,824 | 15,346 | |||||||||||||||||||||||||||||||||
Premises and equipment, net | 1,563 | 1,610 | |||||||||||||||||||||||||||||||||
Accrued interest and other assets | 99,522 | 96,226 | |||||||||||||||||||||||||||||||||
Allowance for loan losses | (13,852) | (14,894) | |||||||||||||||||||||||||||||||||
Total assets | $ | 2,038,094 | $ | 1,866,477 | |||||||||||||||||||||||||||||||
Liabilities and Stockholders' Equity | |||||||||||||||||||||||||||||||||||
Interest - bearing liabilities: | |||||||||||||||||||||||||||||||||||
Interest - bearing deposits: | |||||||||||||||||||||||||||||||||||
Interest checking | $ | 696,460 | $ | 997 | 0.58 | % | $ | 523,712 | $ | 717 | 0.55 | % | |||||||||||||||||||||||
Savings and money markets | 315,695 | 348 | 0.45 | % | 278,774 | 324 | 0.47 | % | |||||||||||||||||||||||||||
Time deposits | 184,605 | 442 | 0.97 | % | 246,486 | 917 | 1.51 | % | |||||||||||||||||||||||||||
Wholesale deposits | 35,000 | 43 | 0.50 | % | 45,778 | 43 | 0.38 | % | |||||||||||||||||||||||||||
Total interest - bearing deposits | 1,231,760 | 1,830 | 0.60 | % | 1,094,750 | 2,001 | 0.74 | % | |||||||||||||||||||||||||||
Other borrowed funds | 44,515 | 342 | 3.12 | % | 69,096 | 734 | 4.31 | % | |||||||||||||||||||||||||||
Total interest-bearing liabilities and interest expense | 1,276,275 | 2,172 | 0.69 | % | 1,163,846 | 2,735 | 0.95 | % | |||||||||||||||||||||||||||
Noninterest-bearing liabilities: | |||||||||||||||||||||||||||||||||||
Demand deposits | 526,239 | 479,831 | |||||||||||||||||||||||||||||||||
Other liabilities | 26,098 | 29,625 | |||||||||||||||||||||||||||||||||
Common stockholders' equity | 209,482 | 193,175 | |||||||||||||||||||||||||||||||||
Total liabilities and stockholders' equity | $ | 2,038,094 | $ | 1,866,477 | |||||||||||||||||||||||||||||||
Net interest income and net interest margin | $ | 15,053 | 3.15 | % | $ | 14,049 | 3.22 | % |
2022 Compared to 2021 | |||||||||||||||||
Average Volume | Average Rate | Increase (Decrease) | |||||||||||||||
Interest income: | |||||||||||||||||
Loans (1): | |||||||||||||||||
Commercial real estate | $ | 1,410 | $ | (378) | $ | 1,032 | |||||||||||
Commercial and industrial | 779 | (279) | 500 | ||||||||||||||
Paycheck protection program | (1,612) | 65 | (1,547) | ||||||||||||||
Commercial construction | (445) | 167 | (278) | ||||||||||||||
Consumer residential | 101 | (44) | 57 | ||||||||||||||
Consumer nonresidential | (88) | (2) | (90) | ||||||||||||||
Total loans (1) | 145 | (471) | (326) | ||||||||||||||
Investment securities (2) | 1,351 | (584) | 767 | ||||||||||||||
Restricted stock | (3) | 3 | — | ||||||||||||||
Deposits at other financial institutions and federal funds sold | (21) | 21 | — | ||||||||||||||
Total interest income | 1,472 | (1,031) | 441 | ||||||||||||||
Interest expense: | |||||||||||||||||
Interest - bearing deposits: | |||||||||||||||||
Interest checking | 237 | 42 | 279 | ||||||||||||||
Savings and money markets | 42 | (18) | 24 | ||||||||||||||
Time deposits | (230) | (245) | (475) | ||||||||||||||
Wholesale deposits | (10) | 10 | — | ||||||||||||||
Total interest - bearing deposits | 39 | (211) | (172) | ||||||||||||||
Other borrowed funds | (253) | (138) | (391) | ||||||||||||||
Total interest expense | (214) | (349) | (563) | ||||||||||||||
Net interest income | $ | 1,686 | $ | (682) | $ | 1,004 |
2022 | 2021 | |||||||||||||
GAAP Financial Measurements: | ||||||||||||||
Interest income: | ||||||||||||||
Loans | $ | 15,607 | $ | 15,933 | ||||||||||
Deposits at other financial institutions and federal funds sold | 45 | 45 | ||||||||||||
Investment securities available‑for‑sale | 1,488 | 717 | ||||||||||||
Investment securities held‑to‑maturity | 1 | 1 | ||||||||||||
Restricted stock | 82 | 82 | ||||||||||||
Total interest income | 17,223 | 16,778 | ||||||||||||
Interest expense: | ||||||||||||||
Interest‑bearing deposits | 1,830 | 2,001 | ||||||||||||
Other borrowed funds | 342 | 734 | ||||||||||||
Total interest expense | 2,172 | 2,735 | ||||||||||||
Net interest income | $ | 15,051 | $ | 14,043 | ||||||||||
Non‑GAAP Financial Measurements: | ||||||||||||||
Add: Tax benefit on tax‑exempt interest income - securities | 2 | 6 | ||||||||||||
Total tax benefit on tax-exempt interest income | $ | 2 | $ | 6 | ||||||||||
Tax equivalent net interest income | $ | 15,053 | $ | 14,049 |
Change from Prior Year | |||||||||||||||||||||||
2022 | 2021 | Amount | Percent | ||||||||||||||||||||
Service charges on deposit accounts | $ | 234 | $ | 243 | $ | (9) | (3.7) | % | |||||||||||||||
Fees on loans | 84 | 20 | 64 | 320.0 | % | ||||||||||||||||||
BOLI income | 238 | 248 | (10) | (4.0) | % | ||||||||||||||||||
Income from minority membership interest | 912 | — | 912 | 100.0 | % | ||||||||||||||||||
Other fee income | 156 | 280 | (124) | (44.3) | % | ||||||||||||||||||
Total non‑interest income | $ | 1,624 | $ | 791 | $ | 833 | 105.3 | % |
Change from Prior Year | |||||||||||||||||||||||
2022 | 2021 | Amount | Percent | ||||||||||||||||||||
Salaries and employee benefits | $ | 4,978 | $ | 4,548 | $ | 430 | 9.5 | % | |||||||||||||||
Occupancy and equipment expense | 840 | 807 | 33 | 4.1 | % | ||||||||||||||||||
Data processing and network administration | 542 | 563 | (21) | (3.7) | % | ||||||||||||||||||
State franchise taxes | 509 | 504 | 5 | 1.0 | % | ||||||||||||||||||
Audit, legal and consulting fees | 361 | 354 | 7 | 2.0 | % | ||||||||||||||||||
Merger and acquisition expense | 125 | — | 125 | 100.0 | % | ||||||||||||||||||
Loan related expenses | 47 | 106 | (59) | (55.7) | % | ||||||||||||||||||
FDIC insurance | 180 | 210 | (30) | (14.3) | % | ||||||||||||||||||
Marketing, business development and advertising | 88 | 49 | 39 | 79.6 | % | ||||||||||||||||||
Director fees | 180 | 138 | 42 | 30.4 | % | ||||||||||||||||||
Postage, courier and telephone | 51 | 46 | 5 | 10.9 | % | ||||||||||||||||||
Internet banking | 143 | 133 | 10 | 7.5 | % | ||||||||||||||||||
Dues, memberships & publications | 48 | 41 | 7 | 17.1 | % | ||||||||||||||||||
Bank insurance | 109 | 101 | 8 | 7.9 | % | ||||||||||||||||||
Printing and supplies | 32 | 23 | 9 | 39.1 | % | ||||||||||||||||||
Bank charges | 28 | 32 | (4) | (12.5) | % | ||||||||||||||||||
State assessments | 31 | 53 | (22) | (41.5) | % | ||||||||||||||||||
Core deposit intangible amortization | 70 | 80 | (10) | (12.5) | % | ||||||||||||||||||
Other operating expenses | 80 | 94 | (14) | (14.9) | % | ||||||||||||||||||
Total non‑interest expense | $ | 8,442 | $ | 7,882 | $ | 560 | 7.1 | % |
March 31, 2022 | December 31, 2021 | ||||||||||
Commercial real estate | $ | 927,780 | $ | 906,112 | |||||||
Commercial and industrial | 184,679 | 174,051 | |||||||||
Paycheck protection program | 13,999 | 28,699 | |||||||||
Commercial construction | 179,483 | 187,615 | |||||||||
Consumer real estate | 202,852 | 200,604 | |||||||||
Consumer nonresidential | 6,851 | 10,304 | |||||||||
Gross loans | 1,515,644 | 1,507,385 | |||||||||
Less: | |||||||||||
Allowance for loan losses | 13,763 | 13,829 | |||||||||
Unearned income and (unamortized premiums) | 3,169 | 3,536 | |||||||||
Loans receivable, net | $ | 1,498,712 | $ | 1,490,020 |
March 31, 2022 | December 31, 2021 | ||||||||||
Nonperforming assets: | |||||||||||
Nonaccrual loans | $ | 3,486 | $ | 3,485 | |||||||
Loans contractually past‑due 90 days or more and still accruing | — | 23 | |||||||||
Total nonperforming loans (NPLs) | $ | 3,486 | $ | 3,508 | |||||||
Other real estate owned | — | — | |||||||||
Total nonperforming assets (NPAs) | $ | 3,486 | $ | 3,508 | |||||||
Performing troubled debt restructurings | $ | 91 | $ | 92 | |||||||
NPLs/Total Assets | 0.17 | % | 0.16 | % | |||||||
NPAs/Total Assets | 0.17 | % | 0.16 | % | |||||||
NPAs and TDRs/Total Assets | 0.17 | % | 0.16 | % | |||||||
Allowance for loan losses/NPLs | 394.81 | % | 394.21 | % |
2022 | 2021 | ||||||||||||||||||||||
Net (charge-offs) recoveries | Percentage of net charge-offs (annualized) to average loans outstanding during the year | Net (charge-offs) recoveries | Percentage of net charge-offs (annualized) to average loans outstanding during the year | ||||||||||||||||||||
Commercial real estate | $ | — | — | % | $ | (427) | (0.12) | % | |||||||||||||||
Commercial and industrial | (396) | (0.10) | % | (117) | (0.03) | % | |||||||||||||||||
Consumer residential | — | — | % | 3 | — | % | |||||||||||||||||
Consumer nonresidential | (19) | (0.01) | % | 4 | — | % | |||||||||||||||||
Total | $ | (415) | (0.11) | % | $ | (537) | (0.15) | % | |||||||||||||||
Average loans outstanding during the period | $ | 1,474,338 | $ | 1,456,310 | |||||||||||||||||||
Allowance for loan losses to loans receivable, net of fees | 0.91 | % | 1.00 | % | |||||||||||||||||||
Allowance for loan losses to loans receivable, net of fees, excluding PPP | 0.92 | % | 1.12 | % |
March 31, | December 31, | ||||||||||||||||||||||
2022 | 2021 | ||||||||||||||||||||||
Allocation | % of Total* | Allocation | % of Total* | ||||||||||||||||||||
Commercial real estate | $ | 9,218 | 61.21 | % | $ | 8,995 | 60.11 | % | |||||||||||||||
Commercial and industrial | 1,987 | 12.19 | % | 1,827 | 11.55 | % | |||||||||||||||||
Paycheck protection program | — | 0.92 | % | — | 1.90 | % | |||||||||||||||||
Commercial construction | 1,772 | 11.84 | % | 2,009 | 12.45 | % | |||||||||||||||||
Consumer real estate | 610 | 13.39 | % | 781 | 13.31 | % | |||||||||||||||||
Consumer nonresidential | 176 | 0.45 | % | 217 | 0.68 | % | |||||||||||||||||
Total allowance for loan losses | $ | 13,763 | 100.00 | % | $ | 13,829 | 100.00 | % |
At March 31, 2022 | ||||||||||||||||||||||||||||||||
Within One Year | One to Five Years | Five to Ten Years | Over Ten Years | Total | ||||||||||||||||||||||||||||
Weighted Average Yield | Weighted Average Yield | Weighted Average Yield | Weighted Average Yield | Weighted Average Yield | ||||||||||||||||||||||||||||
Held‑to‑maturity | ||||||||||||||||||||||||||||||||
Securities of state and local municipalities tax exempt | — | — | 2.32 | % | — | 2.32 | % | |||||||||||||||||||||||||
Total held‑to‑maturity securities | — | — | 2.32 | % | — | 2.32 | % | |||||||||||||||||||||||||
Available‑for‑sale | ||||||||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | — | — | 1.49 | % | — | — | % | |||||||||||||||||||||||||
Securities of state and local municipalities | — | 2.25 | % | — | % | 2.92 | % | 2.44 | % | |||||||||||||||||||||||
Corporate bonds | — | 4.12 | % | 3.94 | % | 4.50 | % | 3.98 | % | |||||||||||||||||||||||
Mortgaged‑backed securities | — | — | 2.28 | % | 1.56 | % | 1.60 | % | ||||||||||||||||||||||||
Total available‑for‑sale securities | — | 3.35 | % | 2.65 | % | 1.57 | % | 1.74 | % | |||||||||||||||||||||||
Total investment securities | — | 3.35 | % | 2.65 | % | 1.57 | % | 1.74 | % |
At December 31, 2021 | ||||||||||||||||||||||||||||||||
Within One Year | One to Five Years | Five to Ten Years | Over Ten Years | Total | ||||||||||||||||||||||||||||
Weighted Average Yield | Weighted Average Yield | Weighted Average Yield | Weighted Average Yield | Weighted Average Yield | ||||||||||||||||||||||||||||
Held‑to‑maturity | ||||||||||||||||||||||||||||||||
Securities of state and local municipalities tax exempt | — | — | 2.32 | % | — | 2.32 | % | |||||||||||||||||||||||||
Total held‑to‑maturity securities | — | — | 2.32 | % | — | 2.32 | % | |||||||||||||||||||||||||
Available‑for‑sale | ||||||||||||||||||||||||||||||||
Securities of U.S. government and federal agencies | — | — | 1.49 | % | — | 1.49 | % | |||||||||||||||||||||||||
Securities of state and local municipalities | — | 2.25 | % | — | % | 2.92 | % | 2.45 | % | |||||||||||||||||||||||
Corporate bonds | — | 3.98 | % | 4.15 | % | — | 4.12 | % | ||||||||||||||||||||||||
Mortgaged‑backed securities | — | — | 2.21 | % | 1.53 | % | 1.57 | % | ||||||||||||||||||||||||
Total available‑for‑sale securities | — | 3.27 | % | 2.51 | % | 1.53 | % | 1.68 | % | |||||||||||||||||||||||
Total investment securities | — | 3.27 | % | 2.51 | % | 1.53 | % | 1.68 | % |
Average Balance | |||||||||||||||||||||||
For the Three Months Ended March 31, 2022 and 2021 | |||||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
March 31, 2022 | March 31, 2021 | ||||||||||||||||||||||
Noninterest bearing demand | $ | 526,239 | 29.93 | % | $ | 479,831 | 30.47 | % | |||||||||||||||
Interest-bearing deposits | |||||||||||||||||||||||
Interest checking | 696,460 | 39.62 | % | 523,712 | 33.26 | % | |||||||||||||||||
Savings and money markets | 315,695 | 17.96 | % | 278,774 | 17.70 | % | |||||||||||||||||
Certificates of deposits, $100,000 to $249,999 | 46,108 | 2.62 | % | 64,191 | 4.08 | % | |||||||||||||||||
Certificates of deposits, $250,000 or more | 138,497 | 7.88 | % | 182,295 | 11.58 | % | |||||||||||||||||
Other time deposits | 35,000 | 1.99 | % | 45,778 | 2.91 | % | |||||||||||||||||
Total | $ | 1,757,999 | 100.00 | % | $ | 1,574,581 | 100.00 | % |
March 31, 2022 | ||||||||
Three months or less | $ | 24,886 | ||||||
Over three months through six months | 15,187 | |||||||
Over six months through twelve months | 28,757 | |||||||
Over twelve months | 12,409 | |||||||
$ | 81,239 |
Actual | For Capital Adequacy Purposes | ||||||||||||||||||||||||||||
Amount | Ratio | Amount | Ratio | ||||||||||||||||||||||||||
At March 31, 2022 | |||||||||||||||||||||||||||||
Leverage capital ratio | $ | 221,633 | 10.96 | % | $ | 182,970 | > | 9.000 | % | ||||||||||||||||||||
At December 31, 2021 | |||||||||||||||||||||||||||||
Leverage capital ratio | $ | 214,442 | 10.55 | % | $ | 172,732 | > | 8.500 | % |
March 31, 2022 | December 31, 2021 | ||||||||||
Total stockholders’ equity | $ | 200,873 | $ | 209,796 | |||||||
Less: goodwill and intangibles, net | (7,982) | (8,052) | |||||||||
Tangible Common Equity | $ | 192,891 | $ | 201,744 | |||||||
Book value per common share | $ | 14.38 | $ | 15.28 | |||||||
Less: intangible book value per common share | (0.57) | (0.58) | |||||||||
Tangible book value per common share | $ | 13.81 | $ | 14.70 |
Interest Rate Risk to Earnings (Net Interest Income) | ||||||||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||||||||
Change in interest rates (basis points) | Percentage change in net interest income | Change in interest rates (basis points) | Percentage change in net interest income | |||||||||||||||||
+400 | 5.39 | % | +400 | 8.57% | ||||||||||||||||
+300 | 4.22 | % | +300 | 6.47% | ||||||||||||||||
+200 | 2.91 | % | +200 | 4.24% | ||||||||||||||||
+100 | 1.47 | % | +100 | 1.99% | ||||||||||||||||
— | — | — | — | |||||||||||||||||
−100 | (3.89 | %) | −100 | (0.49)% | ||||||||||||||||
−200 | (8.49 | %) | −200 | (2.85)% |
Interest Rate Risk to Capital | ||||||||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||||||||
Change in interest rates (basis points) | Percentage change in economic value of equity | Change in interest rates (basis points) | Percentage change in economic value of equity | |||||||||||||||||
+400 | (4.81) | % | +400 | (3.77) | % | |||||||||||||||
+300 | (3.19) | % | +300 | (2.46) | % | |||||||||||||||
+200 | (1.55) | % | +200 | (1.08) | % | |||||||||||||||
+100 | (0.49) | % | +100 | (0.37) | % | |||||||||||||||
0 | — | 0 | — | |||||||||||||||||
−100 | (1.98) | % | −100 | (3.58) | % | |||||||||||||||
−200 | (8.34) | % | −200 | (6.59) | % |
31.1 | |||||
31.2 | |||||
32.1 | |||||
32.2 | |||||
101 | The following materials from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in Extensible Business Reporting Language (XBRL), include: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows, and (vi) related notes. | ||||
104 | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in Inline Extensible Business Reporting Language (included with Exhibit 101). |
FVCBankcorp, Inc. | |||||
(Registrant) | |||||
Date: May 12, 2022 | /s/ David W. Pijor | ||||
David W. Pijor | |||||
Chairman and Chief Executive Officer | |||||
(Principal Executive Officer) | |||||
Date: May 12, 2022 | /s/ Jennifer L. Deacon | ||||
Jennifer L. Deacon | |||||
Executive Vice President and Chief Financial Officer | |||||
(Principal Financial Officer and Principal Accounting Officer) |
Date: May 12, 2022 | /s/ David W. Pijor | ||||
David W. Pijor | |||||
Chairman and Chief Executive Officer |
Date: May 12, 2022 | /s/ Jennifer L. Deacon | ||||
Jennifer L. Deacon | |||||
Executive Vice President and Chief Financial Officer |
Date: May 12, 2022 | /s/ David W. Pijor | ||||
David W. Pijor | |||||
Chairman and Chief Executive Officer |
Date: May 12, 2022 | /s/ Jennifer L. Deacon | ||||
Jennifer L. Deacon | |||||
Executive Vice President and Chief Financial Officer |
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Securities held to maturity, fair value | $ 265 | $ 270 |
Allowance for loan losses | $ 13,763 | $ 13,829 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Common stock, shares issued (in shares) | 13,967,009 | 13,727,045 |
Common stock, shares outstanding (in shares) | 13,967,009 | 13,727,045 |
Consolidated Statements of Income - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Interest and Dividend Income | ||
Interest and fees on loans | $ 15,607 | $ 15,933 |
Interest and dividends on securities held-to-maturity | 1 | 1 |
Interest and dividends on securities available-for-sale | 1,488 | 717 |
Dividends on restricted stock | 82 | 82 |
Interest on deposits at other financial institutions | 45 | 45 |
Total interest and dividend income | 17,223 | 16,778 |
Interest Expense | ||
Interest on deposits | 1,830 | 2,001 |
Interest on short-term debt | 85 | 83 |
Interest on subordinated notes | 257 | 651 |
Total interest expense | 2,172 | 2,735 |
Net Interest Income | 15,051 | 14,043 |
Provision for loan losses | 350 | 0 |
Net interest income after provision for loan losses | 14,701 | 14,043 |
Noninterest Income | ||
Service charges on deposit accounts | 234 | 243 |
BOLI income | 238 | 248 |
Income from minority membership interest | 912 | 0 |
Other income | 240 | 300 |
Total noninterest income | 1,624 | 791 |
Noninterest Expenses | ||
Salaries and employee benefits | 4,978 | 4,548 |
Occupancy and equipment expense | 840 | 807 |
Data processing and network administration | 542 | 563 |
State franchise taxes | 509 | 504 |
Audit, legal and consulting fees | 361 | 354 |
Merger and acquisition expense | 125 | 0 |
Loan related expenses | 47 | 106 |
FDIC insurance | 180 | 210 |
Marketing, business development and advertising | 88 | 49 |
Director fees | 180 | 138 |
Postage, courier and telephone | 51 | 46 |
Internet banking | 143 | 133 |
Core deposit intangible amortization | 70 | 80 |
Other operating expenses | 328 | 344 |
Total noninterest expenses | 8,442 | 7,882 |
Net income before income tax expense | 7,883 | 6,952 |
Income tax expense | 1,270 | 1,383 |
Net income | $ 6,613 | $ 5,569 |
Earnings per share, basic (in dollars per share) | $ 0.48 | $ 0.41 |
Earnings per share, diluted (in dollars per share) | $ 0.45 | $ 0.38 |
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 6,613 | $ 5,569 |
Other comprehensive (loss): | ||
Unrealized loss on securities available for sale, net of tax benefit of $4,700 for the three months ended March 31, 2022 and net of tax benefit of $296 for the three months ended March 31, 2021, respectively. | (17,679) | (1,281) |
Unrealized gain on interest rate swaps, net of tax expense of $135 for the three months ended March 31, 2022 and net of tax expense of $42 for the three months ended March 31, 2021, respectively. | 508 | 156 |
Total other comprehensive loss | (17,171) | (1,125) |
Total comprehensive (loss) income | $ (10,558) | $ 4,444 |
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Statement of Comprehensive Income [Abstract] | ||
Tax benefit securities available for sale | $ 4,700 | $ 296 |
Unrealized gain on interest rate swaps, tax benefit | $ 135 | $ 42 |
Consolidated Statements of Cash Flows - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Cash Flows From Operating Activities | ||
Net income | $ 6,613 | $ 5,569 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation | 111 | 153 |
Provision for loan losses | 350 | 0 |
Net amortization of premium of securities | 171 | 89 |
Net amortization of deferred loan costs and purchase premiums | (635) | (1,697) |
Net accretion of acquisition accounting adjustments | (70) | (129) |
Income from minority membership interest | (912) | 0 |
Amortization of subordinated debt issuance costs | 14 | 31 |
Core deposit intangible amortization | 70 | 80 |
Stock-based compensation expense | 204 | 166 |
BOLI income | (238) | (248) |
Changes in assets and liabilities: | ||
(Increase) decrease in accrued interest receivable, prepaid expenses and other assets | (3,337) | 6,201 |
Increase (decrease) in accrued interest payable, accrued expenses and other liabilities | 1,225 | (4,372) |
Net cash provided by operating activities | 3,566 | 5,843 |
Cash Flows From Investing Activities | ||
Decrease (increase) in interest-bearing deposits at other financial institutions | 94,228 | (83,057) |
Purchases of securities available-for-sale | (46,160) | (21,118) |
Proceeds from maturities and calls of securities available-for-sale | 0 | 1,000 |
Proceeds from redemptions of securities available-for-sale | 10,823 | 9,498 |
Net redemption of restricted stock | 110 | 186 |
Net (increase) decrease in loans | (8,334) | 20,463 |
Distribution received from minority owned investment | 1,040 | 0 |
Purchases of premises and equipment, net | (31) | (19) |
Net cash provided by (used in) investing activities | 51,676 | (73,047) |
Cash Flows From Financing Activities | ||
Net (decrease) increase in noninterest-bearing, interest-bearing checking, savings, and money market deposits | (44,571) | 105,260 |
Net decrease in time deposits | (19,846) | (43,117) |
Common stock issuance | 1,431 | 819 |
Net cash (used in) provided by financing activities | (62,986) | 62,962 |
Net decrease in cash and cash equivalents | (7,744) | (4,242) |
Cash and cash equivalents, beginning of year | 24,613 | 20,835 |
Cash and cash equivalents, end of period | $ 16,869 | $ 16,593 |
Consolidated Statements of Changes in Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Accumulated Other Comprehensive Income |
|||
---|---|---|---|---|---|---|---|---|
Balance at the beginning of the period (in shares) at Dec. 31, 2020 | 13,511 | |||||||
Balance at the beginning of the period at Dec. 31, 2020 | $ 189,500 | $ 135 | $ 119,568 | $ 67,971 | $ 1,826 | |||
Increase (Decrease) in Stockholders' Equity | ||||||||
Net income | 5,569 | 5,569 | ||||||
Other comprehensive loss | (1,125) | (1,125) | ||||||
Common stock issuance for options exercised, net (in shares) | 128 | |||||||
Common stock issuance for options exercised, net | 819 | $ 1 | 818 | |||||
Stock-based compensation expense | 166 | 166 | ||||||
Balance at the end of the period at Mar. 31, 2021 | 194,929 | $ 136 | 120,552 | 73,540 | 701 | |||
Balance at the end of the period (in shares) at Mar. 31, 2021 | 13,639 | |||||||
Balance at the beginning of the period (in shares) at Dec. 31, 2021 | 13,727 | |||||||
Balance at the beginning of the period at Dec. 31, 2021 | 209,796 | [1] | $ 137 | 121,798 | 89,904 | (2,043) | ||
Increase (Decrease) in Stockholders' Equity | ||||||||
Net income | 6,613 | 6,613 | ||||||
Other comprehensive loss | (17,171) | (17,171) | ||||||
Common stock issuance for options exercised, net (in shares) | 212 | |||||||
Common stock issuance for options exercised, net | 1,431 | $ 3 | 1,428 | |||||
Vesting of restricted stock grants (in shares) | 28 | |||||||
Stock-based compensation expense | 204 | 204 | ||||||
Balance at the end of the period at Mar. 31, 2022 | $ 200,873 | $ 140 | $ 123,430 | $ 96,517 | $ (19,214) | |||
Balance at the end of the period (in shares) at Mar. 31, 2022 | 13,967 | |||||||
|
Organization and Summary of Significant Accounting Policies |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Summary of Significant Accounting Policies | Organization and Summary of Significant Accounting Policies Organization FVCBankcorp, Inc. (the Company), a Virginia corporation, was formed in 2015 and is registered as a bank holding company under the Bank Holding Company Act of 1956, as amended. The Company is headquartered in Fairfax, Virginia. The Company conducts its business activities through the branch offices of its wholly owned subsidiary bank, FVCbank (the Bank). The Company exists primarily for the purposes of holding the stock of its subsidiary, the Bank. The Bank was organized under the laws of the Commonwealth of Virginia to engage in a general banking business serving the Washington, D.C. and Baltimore metropolitan areas. The Bank commenced operations on November 27, 2007 and is a member of the Federal Reserve System (the Federal Reserve) and the Federal Deposit Insurance Corporation (FDIC). It is subject to the regulations of the Board of Governors of the Federal Reserve and the State Corporation Commission of Virginia. Consequently, it undergoes periodic examinations by these regulatory authorities. On August 31, 2021, the Company announced that the Bank had made an investment in Atlantic Coast Mortgage, LLC (“ACM”) for $20.4 million. As a result of this investment, the Bank has obtained a 28.7% ownership interest in ACM, which is subject to an earnback option of up to 3.7% over a three year period.. Basis of Presentation The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and follow general practice within the banking industry. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements; however, in the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the results of the interim periods presented have been made. The results of operations for the interim periods are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s audited financial statements for the year ended December 31, 2021. Certain prior period amounts have been reclassified to conform to current period presentation. Principles of Consolidation The consolidated financial statements include the accounts of the Company. All material intercompany balances and transactions have been eliminated in consolidation. Significant Accounting Policies The accounting and reporting policies of the Company are in accordance with GAAP and conform to general practices within the banking industry. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The FASB has issued multiple updates to ASU 2016-13 as codified in Topic 326, including ASUs 2019-04, 2019-05, 2019-10, 2019-11, 2020-02, and 2020-03. These ASUs have provided for various minor technical corrections and improvements to the codification as well as other transition matters. Smaller reporting companies who file with the U.S. Securities and Exchange Commission (SEC), such as the Company, and all other entities who do not file with the SEC are required to apply the guidance for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company has identified a third-party vendor to assist in the measurement of expected credit losses under this standard. The implementation committee has completed the data collection process, validated the data inputs, determined its allowance methodology and is prepared to beginning running the model parallel to the Company’s incurred loss model for the quarter ended March 31, 2022. Effective November 25, 2019, the SEC adopted Staff Accounting Bulletin (SAB) 119. SAB 119 updated portions of SEC interpretative guidance to align with FASB Accounting Standards Codification (ASC) 326, “Financial Instruments - Credit Losses.” It covers topics including (1) measuring current expected credit losses; (2) development, governance, and documentation of a systematic methodology; (3) documenting the results of a systematic methodology; and (4) validating a systematic methodology. In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. Subsequently, in January 2021, the FASB issued ASU 2021-01 “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply ASU 2021-01 on contract modifications that change the interest rate used for margining, discounting, or contract price alignment retrospectively as of any date from the beginning of the interim period that includes March 12, 2020, or prospectively to new modifications from any date within the interim period that includes or is subsequent to January 7, 2021, up to the date that financial statements are available to be issued. An entity may elect to apply ASU 2021-01 to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020, and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. The Company is assessing ASU 2020-04 and its impact on the Company’s transition away from LIBOR for its loan and other financial instruments. In October 2021, the FASB issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers." The ASU requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination and revenue contracts with customers not acquired in a business combination. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022. Entities should apply the amendments prospectively and early adoption is permitted. The Company does not expect the adoption of ASU 2021-08 to have a material impact on its consolidated financial statements. In March 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-02, “Financial Instruments-Credit Losses (Topic 326), Troubled Debt Restructurings and Vintage Disclosures.” ASU 2022-02 addresses areas identified by the FASB as part of its post-implementation review of the credit losses standard (ASU 2016-13) that introduced the CECL model. The amendments eliminate the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require a public business entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures. The amendments in this ASU should be applied prospectively, except for the transition method related to the recognition and measurement of TDRs, an entity has the option to apply a modified retrospective transition method, resulting in a cumulative-effect adjustment to retained earnings in the period of adoption. For entities that have adopted ASU 2016-13, ASU 2022-02 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. For entities that have not yet adopted ASU 2016-13, the effective dates for ASU 2022-02 are the same as the effective dates in ASU 2016-13. Early adoption is permitted if an entity has adopted ASU 2016-13. An entity may elect to early adopt the amendments about TDRs and related disclosure enhancements separately from the amendments related to vintage disclosures. The Company is currently assessing the impact that ASU 2022-02 will have on its (consolidated) financial statements. In March 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-01, “Derivatives and Hedging (Topic 815), Fair Value Hedging—Portfolio Layer Method.” ASU 2022-01 clarifies the guidance in ASC 815 on fair value hedge accounting of interest rate risk for portfolios of financial assets and is intended to better align hedge accounting with an organization’s risk management strategies. In 2017, FASB issued ASU 2017-12 to better align the economic results of risk management activities with hedge accounting. One of the major provisions of that standard was the addition of the last-of-layer hedging method. For a closed portfolio of fixed-rate prepayable financial assets or one or more beneficial interests secured by a portfolio of prepayable financial instruments, such as mortgages or mortgage-backed securities, the last-of-layer method allows an entity to hedge its exposure to fair value changes due to changes in interest rates for a portion of the portfolio that is not expected to be affected by prepayments, defaults, and other events affecting the timing and amount of cash flows. ASU 2022-01 renames that method the portfolio layer method. For public business entities, ASU 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company does not expect the adoption of ASU 2022-01 to have a material impact on its (consolidated) financial statements.
|
Securities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities | Securities Amortized cost and fair values of securities held-to-maturity and securities available-for-sale as of March 31, 2022 and December 31, 2021, are as follows:
The Company had $5.2 million and $5.8 million in securities pledged with the Federal Reserve Bank of Richmond (FRB) to collateralize certain municipal deposits at March 31, 2022 and December 31, 2021, respectively. The Company had $72.8 million in securities pledged with the Virginia Department of Treasury to collateralize certain municipal deposits at March 31, 2022. There were $79.7 million securities pledged to the Virginia Department of Treasury at December 31, 2021. The following table shows fair value and gross unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at March 31, 2022 and December 31, 2021, respectively. The reference point for determining when securities are in an unrealized loss position is month-end. Therefore, it is possible that a security’s market value exceeded its amortized cost on other days during the past twelve-month period. Available-for-sale and held-to-maturity securities that have been in a continuous unrealized loss position are as follows:
Securities of U.S. government and federal agencies: The unrealized losses on three available-for-sale securities were caused by interest rate increases. The contractual terms of these investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Securities of state and local municipalities taxable: The unrealized loss on one of the investments in securities of state and local municipalities was caused by interest rate increases. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. The investment carries an S&P investment grade rating of AAA. Corporate bonds: The unrealized losses on the investments in corporate bonds were caused by interest rate increases. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. One of these investments carries an S&P investment grade rating of BBB+, while one has a rating of BBB-. The remaining 13 investments do not carry a rating. SBA pass-through securities: The unrealized losses on one available-for-sale security was caused by interest rate increases. The contractual terms of these investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Mortgage-backed securities: The unrealized losses on the Company’s investment in 89 mortgage-backed securities were caused by interest rate increases. The contractual cash flows of those investments are guaranteed by an agency of the U.S. Government. Accordingly, it is expected that the securities would not be settled at a price less than the amortized cost basis of the Company’s investments. Because the decline in market value is attributable to changes in interest rates and not credit quality, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022. Collateralized mortgage obligations (CMOs): The unrealized loss associated with 29 CMOs was caused by interest rate increases. The contractual cash flows of these investments are guaranteed by an agency of the U.S. Government. Accordingly, it is expected that the securities would not be settled at a price less than the amortized cost basis of the Company’s investments. Because the decline in market value is attributable to changes in interest rates and not credit quality, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2022. The amortized cost and fair value of securities as of March 31, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without penalties.
For the three months ended March 31, 2022 and 2021, proceeds from principal repayments of securities were $10.8 million and $9.5 million, respectively. During the three months ended March 31, 2022 and 2021, proceeds from calls and maturities of securities were $0 and $1.0 million, respectively. There were no gross realized gains or losses during the three months ended March 31, 2022 and 2021, respectively.
|
Loans and Allowance for Loan Losses |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loans and Allowance for Loan Losses | Loans and Allowance for Loan Losses A summary of loan balances by type follows:
During 2018, as a result of the Company’s acquisition of Colombo Bank (Colombo), the loan portfolio was segregated between loans initially accounted for under the amortized cost method (referred to as “originated” loans) and loans acquired (referred to as “acquired” loans). The loans segregated to the acquired loan portfolio were initially measured at fair value and subsequently accounted for under either ASC 310-30 or ASC 310-20. The outstanding principal balance and related carrying amount of acquired loans included in the consolidated balance sheets as of March 31, 2022 and December 31, 2021 are as follows:
The following table presents changes during the three months ended March 31, 2022 and the year ended December 31, 2021, respectively, in the accretable yield on purchased credit impaired loans for which the Company applies ASC 310-30.
An analysis of the allowance for loan losses for the three months ended March 31, 2022 and 2021, and for the year ended December 31, 2021, follows: Allowance for Loan Losses For the three months ended March 31, 2022 (In thousands)
Allowance for Loan Losses For the three months ended March 31, 2021 (In thousands)
Allowance for Loan Losses For the year ended December 31, 2021 (In thousands)
The following tables present the recorded investment in loans and impairment method as of March 31, 2022 and 2021, and at December 31, 2021, by portfolio segment: Allowance for Loan Losses At March 31, 2022 (In thousands)
Loans Receivable At March 31, 2022 (In thousands)
Allowance for Loan Losses At March 31, 2021 (In thousands)
Loans Receivable At March 31, 2021 (In thousands)
Allowance for Loan Losses At December 31, 2021 (In thousands)
Loans Receivable At December 31, 2021 (In thousands)
Impaired loans by class excluding purchased credit impaired, at March 31, 2022 and December 31, 2021, are summarized as follows: Impaired Loans – Originated Loan Portfolio
Impaired Loans – Originated Loan Portfolio
There were no impaired loans in the acquired loan portfolio at both March 31, 2022 and December 31, 2021, respectively. No additional funds are committed to be advanced in connection with the impaired loans. There were no nonaccrual loans excluded from the impaired loan disclosure. The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as current financial information, historical payment experience, collateral adequacy, credit documentation, and current economic trends, among other factors. The Company analyzes loans individually by classifying the loans as to credit risk. This analysis typically includes larger, non-homogeneous loans such as commercial real estate and commercial and industrial loans. This analysis is performed on an ongoing basis as new information is obtained. The Company uses the following definitions for risk ratings: Pass — Loans listed as pass include larger non-homogeneous loans not meeting the risk rating definitions below and smaller, homogeneous loans not assessed on an individual basis. Special Mention — Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the institution’s credit position at some future date. Substandard — Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the enhanced possibility that the institution will sustain some loss if the deficiencies are not corrected. Doubtful — Loans classified as doubtful include those loans which have all the weaknesses inherent in those classified Substandard with the added characteristic that the weaknesses make collection or liquidation in full, based on currently known facts, conditions and values, improbable. Loss — Loans classified as loss include those loans which are considered uncollectible and of such little value that their continuance as loans is not warranted. Even though partial recovery may be achieved in the future, it is neither practical nor desirable to defer writing off these loans. Based on the most recent analysis performed, the risk category of loans by class of loans was as follows as of March 31, 2022 and December 31, 2021: As of March 31, 2022 – Originated Loan Portfolio
As of March 31, 2022 – Acquired Loan Portfolio
As of December 31, 2021 – Originated Loan Portfolio
As of December 31, 2021 – Acquired Loan Portfolio
The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as current financial information, historical payment experience, collateral adequacy, credit documentation, and current economic trends, among other factors. The Company analyzes loans individually by classifying the loans as to credit risk. This analysis includes larger non-homogeneous loans such as commercial real estate and commercial and industrial loans. This analysis is performed on an ongoing basis as new information is obtained. At March 31, 2022, the Company had $3.3 million in loans identified as special mention, an increase from $3.0 million from December 31, 2021. Special mention rated loans are loans that have a potential weakness that deserves management’s close attention; however, the borrower continues to pay in accordance with their contract. Loans rated as special mention do not have a specific reserve and are considered well-secured. At March 31, 2022, the Company had $16.2 million in loans identified as substandard, a decrease of $2.8 million from December 31, 2021. The decrease in substandard loans was primarily related to two loans totaling $1.8 million which were sold at a discount. Substandard rated loans are loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. For each of these substandard loans, a liquidation analysis is completed. At March 31, 2022, specific reserves on originated and acquired loans totaling $138 thousand has been allocated within the allowance for loan losses to supplement any shortfall of collateral. Past due and nonaccrual loans presented by loan class were as follows at March 31, 2022 and December 31, 2021: As of March 31, 2022 – Originated Loan Portfolio
As of March 31, 2022 – Acquired Loan Portfolio
As of December 31, 2021 – Originated Loan Portfolio
As of December 31, 2021 – Acquired Loan Portfolio
There were no consumer mortgage loans secured by residential real estate properties for which formal foreclosure proceedings were in process as of March 31, 2022 and December 31, 2021, respectively. There were overdrafts of $56 thousand and $58 thousand at March 31, 2022 and December 31, 2021, respectively, which have been reclassified from deposits to loans. At March 31, 2022 and December 31, 2021, loans with a carrying value of $265.6 million and $290.3 million, respectively, were pledged to the Federal Home Loan Bank of Atlanta (FHLB). There were no defaults of TDRs during the twelve months since restructuring for the three months ended March 31, 2022 and 2021. There were no loans designated as TDRs during the three months ended March 31, 2022. The following table presents loans designated as TDRs during the three months ended March 31, 2021: For the three months ended March 31, 2021
As of March 31, 2022 and December 31, 2021, the Company had a recorded investment in TDRs of $91 thousand and $92 thousand, respectively. The concessions made in the TDRs were related to the reduction in the stated interest rate for the remaining life of the debt.
|
Derivative Financial Instruments |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments | Derivative Financial Instruments The Company enters into interest rate swap agreements (swap agreements) to facilitate the risk management strategies needed to accommodate the needs of its banking customers. The Company mitigates the risk of entering into these loan agreements by entering into equal and offsetting swap agreements with highly-rated third party financial institutions. These back-to-back swap agreements are free-standing derivatives and are recorded at fair value in the Company’s consolidated balance sheets (asset positions are included in other assets and liability positions are included in other liabilities) as of March 31, 2022 and December 31, 2021. The Company is party to master netting arrangements with its financial institution counterparty; however, the Company does not offset assets and liabilities under these arrangements for financial statement presentation purposes. The master netting arrangements provide for a single net settlement of all swap agreements, as well as collateral, in the event of default on, or termination of, any one contract. Parties to a centrally cleared over-the-counter derivative exchange daily payments that reflect the daily change in value of the derivative. These payments, commonly referred to as variation margin, are recorded as settlements of the derivatives’ mark-to-market exposure rather than collateral against the exposures, which effectively results in any centrally cleared derivative having a Level 2 fair value that approximates zero on a daily basis, and therefore, these swap agreements were not included in the offsetting table in the Fair Value Measurement section. As of March 31, 2022, the Company had entered into 14 interest rate swap agreements which are collateralized with $0.4 million in cash. There were 19 interest rate swap agreements outstanding as of December 31, 2021 which were collateralized with $6.7 million in cash. The notional amount and fair value of the Company’s derivative financial instruments as of March 31, 2022 and December 31, 2021 were as follows:
Interest Rate Risk Management—Cash Flow Hedging Instruments The Company uses FHLB advances and other wholesale funding from time to time as a source of funds for use in the Company’s lending and investment activities and other general business purposes. This wholesale funding exposes the Company to increased interest rate risk as a result of the variability in cash flows (future interest payments). The Company believes it is prudent to reduce this interest rate risk. To meet this objective, the Company entered into interest rate swap agreements whereby the Company reduces the interest rate risk associated with the Company’s variable rate advances (or other wholesale funding) from the designation date and going through the maturity date. At March 31, 2022 and December 31, 2021, the information pertaining to outstanding interest rate swap agreements used to hedge variability in cash flows (FHLB advances which are included in other borrowed funds on the consolidated balance sheet) and its wholesale deposits (which are included in total deposits on the consolidated balance sheet) was as follows:
These agreements provided for the Company to receive payments determined by a specific index (three month LIBOR) in exchange for making payments at a fixed rate. At March 31, 2022 and December 31, 2021, the unrealized loss relating to interest rate swaps designated as hedging instruments of the variability of cash flows associated with the interest payments on FHLB advances and wholesale deposits are reported in other comprehensive (loss) income. These amounts are subsequently reclassified into interest expense as a yield adjustment in the same period in which the related interest on the advance affects earnings. The Company measures cash flow hedging relationships for effectiveness on a monthly basis, and at March 31, 2022 and December 31, 2021, the hedges were highly effective and the amount of ineffectiveness reflected in earnings was de minimus.
|
Financial Instruments with Off-Balance Sheet Risk |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments with Off-Balance Sheet Risk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments with Off-Balance Sheet Risk | Financial Instruments with Off-Balance Sheet Risk The Company is party to credit-related financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. Such commitments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the balance sheet. The Company’s exposure to credit loss is represented by the contractual amount of these commitments. The Company follows the same credit policies in making commitments as it does for on-balance sheet instruments. At March 31, 2022 and December 31, 2021, the following financial instruments were outstanding, which contract amounts represent credit risk:
Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. The commitments for equity lines of credit may expire without being drawn upon. Therefore, the total commitment amounts do not necessarily represent future cash requirements. The amount of collateral obtained, if it is deemed necessary by the Company, is based on management’s credit evaluation of the customer. Unfunded commitments under commercial lines of credit, revolving credit lines and overdraft protection agreements are commitments for possible future extensions of credit to existing customers. These lines of credit usually do not contain a specified maturity date and may not be drawn upon to the total extent to which the Company is committed. The amount of collateral obtained, if it is deemed necessary by the Company, is based on management’s credit evaluation of the customer. Commercial and standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those letters of credit are primarily issued to support public and private borrowing arrangements. Substantially all letters of credit issued have expiration dates within one year. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. The Company generally holds collateral supporting those commitments, if deemed necessary. The Company enters into rate lock commitments to finance residential mortgage loans with its customers. These commitments offer the borrower an interest rate guarantee provided the loan meets underwriting guidelines and closes within the timeframe established by the Company. The Company maintains its cash accounts with the FRB and correspondent banks. The total amount of cash on deposit in correspondent banks exceeding the federally insured limits was $16.0 million and $32.8 million at March 31, 2022 and December 31, 2021, respectively.
|
Stock-Based Compensation Plan |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation Plan | Stock-Based Compensation Plan The Company’s Amended and Restated 2008 Option Plan (the Plan), which is stockholder-approved, was adopted to advance the interests of the Company by providing selected key employees of the Company, their affiliates, and directors with the opportunity to acquire shares of common stock. In June 2018, the stockholders approved an amendment to Plan to extend the term and increase the number of shares authorized for issuance under the Plan by 200,000 shares. The Company has granted stock options and restricted stock units under the Plan. The maximum number of shares with respect to which awards may be made is 2,529,296 shares of common stock, subject to adjustment for certain corporate events. Option awards are generally granted with an exercise price equal to the market price of the Company’s stock at the date of grant, generally vest annually over four years of continuous service and have ten years contractual terms. At March 31, 2022, 47,392 shares were available to grant under the Plan. No options were granted during the three months ended March 31, 2022 and 2021, respectively. For the three months ended March 31, 2022, there were 4,772 shares withheld from issuance upon exercise of options in order to cover the cost of the exercise by the participant. There were no shares withheld from issuance upon exercise of options in order to cover the cost of the exercise by the participant during the three months ended March 31, 2021, respectively. A summary of option activity under the Plan as of March 31, 2022 and changes during the three months ended is presented below:
(1)The aggregate intrinsic value of stock options represents the total pre-tax intrinsic value (the amount by which the current market value of the underlying stock exceeds the exercise price of the option) that would have been received by the option holders had all option holders exercised their options on March 31, 2022. This amount changes based on changes in the market value of the Company’s common stock. As of March 31, 2022, all outstanding stock options granted under the Plan are fully vested and amortized. There was $204 thousand income tax benefit related to stock options exercised and recognized in the income statement for share-based compensation arrangements for the three months ended March 31, 2022. The total income tax benefit related to stock options exercised and recognized in the income statement for share-based compensation arrangements was $125 thousand for the three months ended March 31, 2021. Restricted stock units relating to 3,000 shares were granted during the three months ended March 31, 2022. There were 116,488 restricted stock units granted during the three months ended March 31, 2021. A summary of the Company’s restricted stock unit grant activity as of March 31, 2022 is shown below.
The compensation cost that has been charged to income for the Plan was $204 thousand and $166 thousand thousand for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, there was $1.9 million of total unrecognized compensation cost related to nonvested restricted stock units granted under the Plan. The cost is expected to be recognized over a weighted-average period of 28 months.
|
Fair Value Measurements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements | Fair Value Measurements Determination of Fair Value The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. In accordance with Fair Value Measurements and Disclosures topic of FASB ASC, the fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date (exit price). Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for the Company’s various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument. The fair value guidance provides a consistent definition of fair value, which focuses on exit price in an orderly transaction (that is, not a forced liquidation or distressed sale) between market participants at the measurement date under current market conditions. If there has been a significant decrease in the volume and level of activity for the asset or liability, a change in valuation technique or the use of multiple valuation techniques may be appropriate. In such instances, determining the price at which willing market participants would transact at the measurement date under current market conditions depends on the facts and circumstances and requires the use of significant judgment. The fair value is a reasonable point within the range that is most representative of fair value under current market conditions. Fair Value Hierarchy In accordance with this guidance, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.
The following describes the valuation techniques used by the Company to measure certain financial assets and liabilities recorded at fair value on a recurring basis in the financial statements: Securities available-for-sale: Securities available-for-sale are recorded at fair value on a recurring basis. Fair value measurement is based upon quoted market prices, when available (Level 1). If quoted market prices are not available, fair values are measured utilizing independent valuation techniques of identical or similar securities for which significant assumptions are derived primarily from or corroborated by observable market data. Third party vendors compile prices from various sources and may determine the fair value of identical or similar securities by using pricing models that considers observable market data (Level 2). Cash flow hedges: The Company has interest rate swap derivatives that are designated as cash flow hedges and are recorded at fair value using published yield curve rates from a national valuation service. These observable rates and inputs are applied to a third party industry-wide valuation model, and therefore, the valuations fall into a Level 2 category. The following table presents the balances of financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021:
Certain financial assets are measured at fair value on a nonrecurring basis in accordance with GAAP. Adjustments to the fair value of these assets usually result from the application of lower of cost or market accounting or write-downs of individual assets. The following describes the valuation techniques used by the Company to measure certain financial assets recorded at fair value on a nonrecurring basis in the financial statements: Impaired Loans: Loans are designated as impaired when, in the judgment of management based on current information and events, it is probable that all amounts due according to the contractual terms of the loan agreement will not be collected. The measurement of loss associated with impaired loans can be based on either the present value of future cash flows, observable market price of the loan or the fair value of the collateral. Fair value is measured based on the value of the collateral securing the loans. Collateral may be in the form of real estate or business assets including equipment, inventory, and accounts receivable. The vast majority of the collateral is real estate. The value of real estate collateral is determined utilizing a market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Company using observable market data (Level 2). However, if the collateral is a house or building in the process of construction, has the value derived by discounting comparable sales due to lack of similar properties, or is discounted by the Company due to marketability, then the fair value is considered Level 3. The value of business equipment is based upon an outside appraisal if deemed significant, or the net book value on the applicable business’s financial statements if not considered significant using observable market data. Likewise, values for inventory and accounts receivables collateral are based on financial statement balances or aging reports (Level 3). Impaired loans allocated to the allowance for loan losses are measured at fair value on a nonrecurring basis. Any fair value adjustments are recorded in the period incurred as provision for loan losses on the Consolidated Statements of Income. The following table summarizes the Company’s assets that were measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021:
The following table displays quantitative information about Level 3 Fair Value Measurements for March 31, 2022 and December 31, 2021:
The following presents the carrying amount, fair value and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2022 and December 31, 2021. Fair values for March 31, 2022 and December 31, 2021 are estimated under the exit price notion in accordance with ASU 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities.”
|
Earnings Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share Basic earnings per share excludes dilution and is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if contracts to issue common stock were exercised or converted into common stock, or resulted in the issuance of stock which then shared in the earnings of the Company. Holders of the Company’s restricted stock units do not have voting rights during the vesting period and therefore, restricted stock units are not included in the computation of basic earnings per share. Weighted average shares – diluted includes the potential dilution of stock options and restricted stock units as of March 31, 2022. The weighted average shares – diluted as of March 31, 2021 includes only the potential dilution of stock options. The following shows the weighted average number of shares used in computing earnings per share and the effect of weighted average number of shares of dilutive potential common stock. Dilutive potential common stock has no effect on income available to common stockholders. There were no anti-dilutive shares for each of the periods ended March 31, 2022 and March 31, 2021.
|
Accumulated Other Comprehensive Income (Loss) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statement of Other Comprehensive Income [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) Changes in accumulated other comprehensive income (AOCI) for the three months ended March 31, 2022 and 2021 are shown in the following table. The Company has two components, which are available-for-sale securities and cash flow hedges, for the periods presented.
|
Subordinated Notes |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Subordinated Borrowings [Abstract] | |
Subordinated Notes | Subordinated Notes On June 20, 2016, the Company issued $25 million of fixed-to-floating rate subordinated notes due June 30, 2026, in a private placement to accredited investors. Interest was payable at 6.00% per annum, from and including June 20, 2016 to, but excluding, June 30, 2021, semi-annually in arrears. From and including June 30, 2021 to the maturity date or early redemption date, the interest rate was to reset quarterly to an interest rate per annum equal to the then current three-month LIBOR rate plus 487 basis points, payable quarterly in arrears. The Company had the option, on any scheduled interest payment date, to redeem the subordinated notes, in whole or in part, upon not fewer than 30 nor greater than 60 days’ notice to holders, at a redemption price equal to 100% of the principal amount of the subordinated notes to be redeemed plus accrued and unpaid interest to, but excluding, the date of redemption. In August 2021, the Company provided a redemption notice to each holder of the subordinated notes that the notes would be redeemed on September 30, 2021 or such later date as the holder returned its note to the Company. $23.8 million of principal was redeemed and paid during the year ended December 31, 2021. The remaining note holders redeemed their notes with a principal balance of $1.2 million in February 2022. The notes stopped accruing interest effective as of September 30, 2021 redemption date. On October 13, 2020, the Company completed its private placement of $20.0 million of its 4.875% Fixed to Floating Subordinated Notes due 2030 (the Notes) to certain qualified institutional buyers and accredited investors. The Notes have a maturity date of October 15, 2030 and carry a fixed rate of interest of 4.875% for the first five years. Thereafter, the Notes will pay interest at 3-month SOFR plus 471 basis points, resetting quarterly. The Notes include a right of prepayment without penalty on or after October 15, 2025. The Notes have been structured to qualify as Tier 2 capital for regulatory purposes.
|
Revenue Recognition |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | Revenue Recognition The Company recognizes revenue in accordance with ASU 2014-09 ‘‘Revenue from Contracts with Customers’’ (Topic 606) and all subsequent ASUs that modified Topic 606 in recognizing revenue. Topic 606 does not apply to revenue associated with financial instruments, including revenue from loans and securities. In addition, certain noninterest income streams such as fees associated with mortgage servicing rights, gain on sale of securities, bank-owned life insurance income, financial guarantees, derivatives, and certain credit card fees are also not in scope of the new guidance. Topic 606 is applicable to noninterest revenue streams such as trust and asset management income, deposit related fees, interchange fees, merchant income, and insurance commissions. However, the recognition of these revenue streams did not change significantly upon adoption of Topic 606. Substantially all of the Company’s revenue is generated from contracts with customers. Noninterest revenue streams in-scope of Topic 606 are discussed below. Service Charges on Deposit Accounts Service charges on deposit accounts consist of account analysis fees (i.e., net fees earned on analyzed business and personal checking accounts), monthly service fees, check orders, and other deposit account related fees. The Company’s performance obligation for account analysis fees and monthly service fees is generally satisfied, and the related revenue recognized, over the period in which the service is provided. Check orders and other deposit account related fees are largely transactional based, and therefore, the Company’s performance obligation is satisfied, and related revenue recognized, at a point in time. Payment for service charges on deposit accounts is primarily received immediately or in the following month through a direct charge to customers’ accounts. Fees, Exchange and Other Service Charges Fees, exchange, and other service charges are primarily comprised of debit and credit card income, ATM fees, merchant services income, and other service charges and are included in other income on the Company’s consolidated statements of income. Debit and credit card income is primarily comprised of interchange fees earned whenever the Company’s debit and credit cards are processed through card payment networks such as Visa. ATM fees are primarily generated when a Company cardholder uses a non-Company ATM or a non-Company cardholder uses a Company ATM. Merchant services income mainly represents fees charged to merchants to process their debit and credit card transactions, in addition to account management fees. Other service charges include revenue from processing wire transfers, bill pay service, cashier’s checks, and other services. The Company’s performance obligation for fees, exchange, and other service charges are largely satisfied, and related revenue recognized, when the services are rendered or upon completion. Payment is typically received immediately or in the following month. This income is reflected in other income on the Company’s consolidated statements of income. Other income Other noninterest income consists of loan swap fees, insurance commissions, and other miscellaneous revenue streams not meeting the criteria above. When the Company enters into an interest rate swap agreement, the Company may receive an additional one-time payment fee which is recognized as income when received. The Company receives monthly recurring commissions based on a percentage of premiums issued and revenue is recognized when received. Any residual miscellaneous fees are recognized as they occur, and therefore, the Company determined this consistent practice satisfies the obligation for performance. The following presents noninterest income, segregated by revenue streams in-scope and out-of-scope of Topic 606, for the three months ended March 31, 2022 and 2021:
Contract Balances A contract asset balance occurs when an entity performs a service for a customer before the customer pays consideration (resulting in a contract receivable) or before payment is due (resulting in a contract asset). A contract liability balance is an entity’s obligation to transfer a service to a customer for which the entity has already received payment (or payment is due) from the customer. The Company’s noninterest revenue streams are largely based on transactional activity. Consideration is often received immediately or shortly after the Company satisfies its performance obligation and revenue is recognized. The Company does not typically enter into long-term revenue contracts with customers, and therefore, does not experience significant contract balances. As of March 31, 2022 and 2021, the Company did not have any significant contract balances. Contract Acquisition Costs Under Topic 606, an entity is required to capitalize, and subsequently amortize into expense, certain incremental costs of obtaining a contract with a customer if these costs are expected to be recovered. The incremental costs of obtaining a contract are those costs that an entity incurs to obtain a contract with a customer that it would not have incurred if the contract had not been obtained (for example, sales commission). The Company utilizes the practical expedient which allows entities to immediately expense contract acquisition costs when the asset that would have resulted from capitalizing these costs would have been amortized in one year or less. The Company did not capitalize any contract acquisition cost during the three months ended March 31, 2022 or 2021.
|
Supplemental Cash Flow Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental Cash Flow Information [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental Cash Flow Information | Supplemental Cash Flow Information Below is additional information regarding the Company’s cash flows for the three months ended March 31, 2022 and 2021.
|
Organization and Summary of Significant Accounting Policies (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and follow general practice within the banking industry. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements; however, in the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the results of the interim periods presented have been made. The results of operations for the interim periods are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s audited financial statements for the year ended December 31, 2021. Certain prior period amounts have been reclassified to conform to current period presentation.
|
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company. All material intercompany balances and transactions have been eliminated in consolidation.
|
Recent Accounting Pronouncements | Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The amendments in this ASU, among other things, require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. In addition, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The FASB has issued multiple updates to ASU 2016-13 as codified in Topic 326, including ASUs 2019-04, 2019-05, 2019-10, 2019-11, 2020-02, and 2020-03. These ASUs have provided for various minor technical corrections and improvements to the codification as well as other transition matters. Smaller reporting companies who file with the U.S. Securities and Exchange Commission (SEC), such as the Company, and all other entities who do not file with the SEC are required to apply the guidance for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company has identified a third-party vendor to assist in the measurement of expected credit losses under this standard. The implementation committee has completed the data collection process, validated the data inputs, determined its allowance methodology and is prepared to beginning running the model parallel to the Company’s incurred loss model for the quarter ended March 31, 2022. Effective November 25, 2019, the SEC adopted Staff Accounting Bulletin (SAB) 119. SAB 119 updated portions of SEC interpretative guidance to align with FASB Accounting Standards Codification (ASC) 326, “Financial Instruments - Credit Losses.” It covers topics including (1) measuring current expected credit losses; (2) development, governance, and documentation of a systematic methodology; (3) documenting the results of a systematic methodology; and (4) validating a systematic methodology. In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. Subsequently, in January 2021, the FASB issued ASU 2021-01 “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply ASU 2021-01 on contract modifications that change the interest rate used for margining, discounting, or contract price alignment retrospectively as of any date from the beginning of the interim period that includes March 12, 2020, or prospectively to new modifications from any date within the interim period that includes or is subsequent to January 7, 2021, up to the date that financial statements are available to be issued. An entity may elect to apply ASU 2021-01 to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020, and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. The Company is assessing ASU 2020-04 and its impact on the Company’s transition away from LIBOR for its loan and other financial instruments. In October 2021, the FASB issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers." The ASU requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. The amendments improve comparability after the business combination by providing consistent recognition and measurement guidance for revenue contracts with customers acquired in a business combination and revenue contracts with customers not acquired in a business combination. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2022. Entities should apply the amendments prospectively and early adoption is permitted. The Company does not expect the adoption of ASU 2021-08 to have a material impact on its consolidated financial statements. In March 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-02, “Financial Instruments-Credit Losses (Topic 326), Troubled Debt Restructurings and Vintage Disclosures.” ASU 2022-02 addresses areas identified by the FASB as part of its post-implementation review of the credit losses standard (ASU 2016-13) that introduced the CECL model. The amendments eliminate the accounting guidance for troubled debt restructurings by creditors that have adopted the CECL model and enhance the disclosure requirements for loan refinancings and restructurings made with borrowers experiencing financial difficulty. In addition, the amendments require a public business entity to disclose current-period gross write-offs for financing receivables and net investment in leases by year of origination in the vintage disclosures. The amendments in this ASU should be applied prospectively, except for the transition method related to the recognition and measurement of TDRs, an entity has the option to apply a modified retrospective transition method, resulting in a cumulative-effect adjustment to retained earnings in the period of adoption. For entities that have adopted ASU 2016-13, ASU 2022-02 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. For entities that have not yet adopted ASU 2016-13, the effective dates for ASU 2022-02 are the same as the effective dates in ASU 2016-13. Early adoption is permitted if an entity has adopted ASU 2016-13. An entity may elect to early adopt the amendments about TDRs and related disclosure enhancements separately from the amendments related to vintage disclosures. The Company is currently assessing the impact that ASU 2022-02 will have on its (consolidated) financial statements. In March 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2022-01, “Derivatives and Hedging (Topic 815), Fair Value Hedging—Portfolio Layer Method.” ASU 2022-01 clarifies the guidance in ASC 815 on fair value hedge accounting of interest rate risk for portfolios of financial assets and is intended to better align hedge accounting with an organization’s risk management strategies. In 2017, FASB issued ASU 2017-12 to better align the economic results of risk management activities with hedge accounting. One of the major provisions of that standard was the addition of the last-of-layer hedging method. For a closed portfolio of fixed-rate prepayable financial assets or one or more beneficial interests secured by a portfolio of prepayable financial instruments, such as mortgages or mortgage-backed securities, the last-of-layer method allows an entity to hedge its exposure to fair value changes due to changes in interest rates for a portion of the portfolio that is not expected to be affected by prepayments, defaults, and other events affecting the timing and amount of cash flows. ASU 2022-01 renames that method the portfolio layer method. For public business entities, ASU 2022-01 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The Company does not expect the adoption of ASU 2022-01 to have a material impact on its (consolidated) financial statements.
|
Securities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amortized cost and fair values of securities held-to-maturity and securities available-for-sale | Amortized cost and fair values of securities held-to-maturity and securities available-for-sale as of March 31, 2022 and December 31, 2021, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of available-for-sale securities that have been in a continuous unrealized loss position | Available-for-sale and held-to-maturity securities that have been in a continuous unrealized loss position are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amortized cost and fair value of held-to-maturity securities and available-for-sale securities by contractual maturity | The amortized cost and fair value of securities as of March 31, 2022, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without penalties.
|
Loans and Allowance for Loan Losses (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of loan balances | A summary of loan balances by type follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of acquired loans | The loans segregated to the acquired loan portfolio were initially measured at fair value and subsequently accounted for under either ASC 310-30 or ASC 310-20. The outstanding principal balance and related carrying amount of acquired loans included in the consolidated balance sheets as of March 31, 2022 and December 31, 2021 are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of accretable yield on purchased credit impaired loans | The following table presents changes during the three months ended March 31, 2022 and the year ended December 31, 2021, respectively, in the accretable yield on purchased credit impaired loans for which the Company applies ASC 310-30.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of allowance for loan losses | An analysis of the allowance for loan losses for the three months ended March 31, 2022 and 2021, and for the year ended December 31, 2021, follows: Allowance for Loan Losses For the three months ended March 31, 2022 (In thousands)
Allowance for Loan Losses For the three months ended March 31, 2021 (In thousands)
Allowance for Loan Losses For the year ended December 31, 2021 (In thousands)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of recorded investment in loans and impairment by portfolio segment | The following tables present the recorded investment in loans and impairment method as of March 31, 2022 and 2021, and at December 31, 2021, by portfolio segment: Allowance for Loan Losses At March 31, 2022 (In thousands)
Loans Receivable At March 31, 2022 (In thousands)
Allowance for Loan Losses At March 31, 2021 (In thousands)
Loans Receivable At March 31, 2021 (In thousands)
Allowance for Loan Losses At December 31, 2021 (In thousands)
Loans Receivable At December 31, 2021 (In thousands)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Impaired loans | Impaired loans by class excluding purchased credit impaired, at March 31, 2022 and December 31, 2021, are summarized as follows: Impaired Loans – Originated Loan Portfolio
Impaired Loans – Originated Loan Portfolio
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of risk category of loans | Based on the most recent analysis performed, the risk category of loans by class of loans was as follows as of March 31, 2022 and December 31, 2021: As of March 31, 2022 – Originated Loan Portfolio
As of March 31, 2022 – Acquired Loan Portfolio
As of December 31, 2021 – Originated Loan Portfolio
As of December 31, 2021 – Acquired Loan Portfolio
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of past due and nonaccrual loans | Past due and nonaccrual loans presented by loan class were as follows at March 31, 2022 and December 31, 2021: As of March 31, 2022 – Originated Loan Portfolio
As of March 31, 2022 – Acquired Loan Portfolio
As of December 31, 2021 – Originated Loan Portfolio
As of December 31, 2021 – Acquired Loan Portfolio
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of TDR's originated | The following table presents loans designated as TDRs during the three months ended March 31, 2021: For the three months ended March 31, 2021
|
Derivative Financial Instruments (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of notional amount and fair value of derivative financial instruments | The notional amount and fair value of the Company’s derivative financial instruments as of March 31, 2022 and December 31, 2021 were as follows:
|
Financial Instruments with Off-Balance Sheet Risk (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments with Off-Balance Sheet Risk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial instruments outstanding which contract amounts represent credit risk | At March 31, 2022 and December 31, 2021, the following financial instruments were outstanding, which contract amounts represent credit risk:
|
Stock-Based Compensation Plan (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of option activity | A summary of option activity under the Plan as of March 31, 2022 and changes during the three months ended is presented below:
(1)The aggregate intrinsic value of stock options represents the total pre-tax intrinsic value (the amount by which the current market value of the underlying stock exceeds the exercise price of the option) that would have been received by the option holders had all option holders exercised their options on March 31, 2022. This amount changes based on changes in the market value of the Company’s common stock.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of restricted stock grant activity | A summary of the Company’s restricted stock unit grant activity as of March 31, 2022 is shown below.
|
Fair Value Measurements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial assets and liabilities measured at fair value on a recurring basis | The following table presents the balances of financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of the Company's assets that were measured at fair value on a nonrecurring basis | The following table summarizes the Company’s assets that were measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of quantitative information about Level 3 Fair Value Measurements | The following table displays quantitative information about Level 3 Fair Value Measurements for March 31, 2022 and December 31, 2021:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of carrying amount, fair value and placement in the fair value hierarchy of the Company's financial instruments | The following presents the carrying amount, fair value and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2022 and December 31, 2021. Fair values for March 31, 2022 and December 31, 2021 are estimated under the exit price notion in accordance with ASU 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities.”
|
Earnings Per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of earning per share | The following shows the weighted average number of shares used in computing earnings per share and the effect of weighted average number of shares of dilutive potential common stock. Dilutive potential common stock has no effect on income available to common stockholders. There were no anti-dilutive shares for each of the periods ended March 31, 2022 and March 31, 2021.
|
Accumulated Other Comprehensive Income (Loss) (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statement of Other Comprehensive Income [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in accumulated other comprehensive income (AOCI) | Changes in accumulated other comprehensive income (AOCI) for the three months ended March 31, 2022 and 2021 are shown in the following table. The Company has two components, which are available-for-sale securities and cash flow hedges, for the periods presented.
|
Revenue Recognition (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of noninterest income | The following presents noninterest income, segregated by revenue streams in-scope and out-of-scope of Topic 606, for the three months ended March 31, 2022 and 2021:
|
Supplemental Cash Flow Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental Cash Flow Information [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of supplemental cash flow information | Below is additional information regarding the Company’s cash flows for the three months ended March 31, 2022 and 2021.
|
Organization and Summary of Significant Accounting Policies (Details) $ in Millions |
1 Months Ended |
---|---|
Aug. 31, 2021
USD ($)
| |
Schedule of Equity Method Investments [Line Items] | |
Earn back option period | 3 years |
Atlantic Coast Mortgage, LLC | |
Schedule of Equity Method Investments [Line Items] | |
Investment amount | $ 20.4 |
Ownership percentage | 28.70% |
Earn back percentage | 3.70% |
Securities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Held-to-maturity | |||||
Total | $ 264 | $ 264 | [1] | ||
Gross Unrealized Gains | 1 | 6 | |||
Gross Unrealized (Losses) | 0 | 0 | |||
Fair Value | 265 | 270 | |||
Available-for-sale | |||||
Total | 355,281 | 360,339 | |||
Gross Unrealized Gains | 219 | 1,783 | |||
Gross Unrealized (Losses) | (25,163) | (4,348) | |||
Fair Value | 330,337 | 357,774 | [1] | ||
Securities of state and local municipalities - tax exempt | |||||
Held-to-maturity | |||||
Total | 264 | 264 | |||
Gross Unrealized Gains | 1 | 6 | |||
Gross Unrealized (Losses) | 0 | 0 | |||
Fair Value | 265 | 270 | |||
Available-for-sale | |||||
Total | 1,391 | 1,393 | |||
Gross Unrealized Gains | 8 | 58 | |||
Gross Unrealized (Losses) | 0 | 0 | |||
Fair Value | 1,399 | 1,451 | |||
Securities of U.S. government and federal agencies | |||||
Available-for-sale | |||||
Total | 13,558 | 13,719 | |||
Gross Unrealized Gains | 0 | 0 | |||
Gross Unrealized (Losses) | (1,223) | (283) | |||
Fair Value | 12,335 | 13,436 | |||
Securities of state and local municipalities - taxable | |||||
Available-for-sale | |||||
Total | 570 | 607 | |||
Gross Unrealized Gains | 0 | 0 | |||
Gross Unrealized (Losses) | (21) | (11) | |||
Fair Value | 549 | 596 | |||
Corporate bonds | |||||
Available-for-sale | |||||
Total | 20,218 | 13,970 | |||
Gross Unrealized Gains | 81 | 259 | |||
Gross Unrealized (Losses) | (418) | (78) | |||
Fair Value | 19,881 | 14,151 | |||
SBA pass-through securities | |||||
Available-for-sale | |||||
Total | 92 | 107 | |||
Gross Unrealized Gains | 0 | 1 | |||
Gross Unrealized (Losses) | (4) | 0 | |||
Fair Value | 88 | 108 | |||
Mortgage-backed securities | |||||
Available-for-sale | |||||
Total | 307,010 | 316,313 | |||
Gross Unrealized Gains | 120 | 1,352 | |||
Gross Unrealized (Losses) | (22,860) | (3,827) | |||
Fair Value | 284,270 | 313,838 | |||
Collateralized mortgage obligations | |||||
Available-for-sale | |||||
Total | 12,442 | 14,230 | |||
Gross Unrealized Gains | 10 | 113 | |||
Gross Unrealized (Losses) | (637) | (149) | |||
Fair Value | 11,815 | 14,194 | |||
Federal Reserve Bank | |||||
Available-for-sale | |||||
Pledged securities | 5,200 | 5,800 | |||
Virginia Department Of Treasury | |||||
Available-for-sale | |||||
Pledged securities | $ 72,800 | $ 79,700 | |||
|
Securities - Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | $ 278,997 | $ 237,432 |
Fair Value, 12 Months or Longer | 28,427 | 21,039 |
Fair Value, Total | 307,424 | 258,471 |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (21,972) | (3,629) |
Unrealized Losses, 12 Months or Longer | (3,191) | (719) |
Unrealized Losses, Total | (25,163) | (4,348) |
Securities of U.S. government and federal agencies | ||
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | 12,335 | 13,275 |
Fair Value, 12 Months or Longer | 0 | 0 |
Fair Value, Total | 12,335 | 13,275 |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (1,223) | (283) |
Unrealized Losses, 12 Months or Longer | 0 | 0 |
Unrealized Losses, Total | (1,223) | (283) |
Securities of state and local municipalities - taxable | ||
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | 549 | 595 |
Fair Value, 12 Months or Longer | 0 | 0 |
Fair Value, Total | 549 | 595 |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (21) | (11) |
Unrealized Losses, 12 Months or Longer | 0 | 0 |
Unrealized Losses, Total | (21) | (11) |
Corporate bonds | ||
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | 11,581 | 3,922 |
Fair Value, 12 Months or Longer | 0 | 0 |
Fair Value, Total | 11,581 | 3,922 |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (418) | (78) |
Unrealized Losses, 12 Months or Longer | 0 | 0 |
Unrealized Losses, Total | (418) | (78) |
SBA pass-through securities | ||
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | 88 | |
Fair Value, 12 Months or Longer | 0 | |
Fair Value, Total | 88 | |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (4) | |
Unrealized Losses, 12 Months or Longer | 0 | |
Unrealized Losses, Total | (4) | |
Mortgage-backed securities | ||
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | 246,978 | 216,278 |
Fair Value, 12 Months or Longer | 25,240 | 19,225 |
Fair Value, Total | 272,218 | 235,503 |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (20,021) | (3,175) |
Unrealized Losses, 12 Months or Longer | (2,839) | (652) |
Unrealized Losses, Total | (22,860) | (3,827) |
Collateralized mortgage obligations | ||
Available-for-sale securities, Continuous Unrealized Loss Position, Fair Value | ||
Fair Value, Less than 12 Months | 7,466 | 3,362 |
Fair Value, 12 Months or Longer | 3,187 | 1,814 |
Fair Value, Total | 10,653 | 5,176 |
Available-for-sale securities, Continuous Unrealized Loss Position, Gross Unrealized Losses | ||
Unrealized Losses, Less than 12 Months | (285) | (82) |
Unrealized Losses, 12 Months or Longer | (352) | (67) |
Unrealized Losses, Total | $ (637) | $ (149) |
Securities - Continuous Unrealized Loss Position - Additional information (Details) |
3 Months Ended |
---|---|
Mar. 31, 2022
security
| |
Securities of U.S. government and federal agencies | |
Debt Securities, Available-for-sale | |
Number of investment securities | 3 |
Securities of state and local municipalities - taxable | |
Debt Securities, Available-for-sale | |
Number of investment securities | 1 |
Corporate bonds | BBB+ | |
Debt Securities, Available-for-sale | |
Number of investment securities | 1 |
Corporate bonds | BB | |
Debt Securities, Available-for-sale | |
Number of investment securities | 1 |
Corporate bonds | No rating | |
Debt Securities, Available-for-sale | |
Number of investment securities | 13 |
SBA pass-through securities | |
Debt Securities, Available-for-sale | |
Number of investment securities | 1 |
Mortgage-backed securities | |
Debt Securities, Available-for-sale | |
Number of investment securities | 89 |
Collateralized mortgage obligations | |
Debt Securities, Available-for-sale | |
Number of investment securities | 29 |
Securities - Contractual Maturities (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Held-to-maturity, Amortized Cost | |||||
After 1 year through 5 years | $ 0 | ||||
After 5 years through 10 years | 264 | ||||
After 10 years | 0 | ||||
Total | 264 | $ 264 | [1] | ||
Held-to-maturity, Fair Value | |||||
After 1 year through 5 years | 0 | ||||
After 5 years through 10 years | 265 | ||||
After 10 years | 0 | ||||
Total | 265 | 270 | |||
Available-for-sale, Amortized Cost | |||||
After 1 year through 5 years | 3,391 | ||||
After 5 years through 10 years | 48,263 | ||||
After 10 years | 303,627 | ||||
Total | 355,281 | ||||
Available-for-sale, Fair Value | |||||
After 1 year through 5 years | 3,372 | ||||
After 5 years through 10 years | 46,539 | ||||
After 10 years | 280,426 | ||||
Total | $ 330,337 | $ 357,774 | [1] | ||
|
Securities - Contractual Maturities - Additional Information (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Investments, Debt and Equity Securities [Abstract] | ||
Proceeds from maturities, calls and principal repayments of securities | $ 10,800,000 | $ 9,500,000 |
Proceeds from calls and maturities of securities | 0 | 1,000,000 |
Gross realized loss on securities | $ 0 | $ 0 |
Loans and Allowance for Loan Losses - Summary of loan balances by type (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
|||
---|---|---|---|---|---|---|---|
Loans and Allowance for Loan Losses | |||||||
Loans, gross | $ 1,515,644 | $ 1,507,385 | $ 1,452,402 | ||||
Allowance for loan losses | 13,763 | 13,829 | 14,421 | $ 14,958 | |||
Unearned income and (unamortized premiums), net | 3,169 | 3,536 | |||||
Loans, net | 1,498,712 | 1,490,020 | [1] | ||||
Commercial | Real Estate | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 927,780 | 906,112 | 783,783 | ||||
Allowance for loan losses | 9,218 | 8,995 | 9,078 | 9,291 | |||
Commercial | Commercial and Industrial | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 198,678 | 202,750 | 276,621 | ||||
Allowance for loan losses | 1,987 | 1,827 | 2,313 | 2,546 | |||
Commercial | Construction | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 179,483 | 187,615 | 219,187 | ||||
Allowance for loan losses | 1,772 | 2,009 | 1,983 | 1,960 | |||
Consumer | Real Estate | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 202,852 | 200,604 | 159,217 | ||||
Allowance for loan losses | 610 | 781 | 652 | 690 | |||
Consumer | Nonresidential | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 6,851 | 10,304 | 13,594 | ||||
Allowance for loan losses | 176 | 217 | $ 395 | $ 471 | |||
Originated Loan Portfolio | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 1,472,340 | 1,459,881 | |||||
Allowance for loan losses | 13,763 | 13,829 | |||||
Unearned income and (unamortized premiums), net | 3,169 | 3,536 | |||||
Loans, net | 1,455,408 | 1,442,516 | |||||
Originated Loan Portfolio | Commercial | Real Estate | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 910,630 | 887,310 | |||||
Originated Loan Portfolio | Commercial | Commercial and Industrial | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 195,081 | 199,040 | |||||
Originated Loan Portfolio | Commercial | Construction | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 178,680 | 186,572 | |||||
Originated Loan Portfolio | Consumer | Real Estate | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 181,123 | 176,682 | |||||
Originated Loan Portfolio | Consumer | Nonresidential | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 6,826 | 10,277 | |||||
Acquired Loan Portfolio | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 43,304 | 47,504 | |||||
Allowance for loan losses | 0 | 0 | |||||
Unearned income and (unamortized premiums), net | 0 | 0 | |||||
Loans, net | 43,304 | 47,504 | |||||
Acquired Loan Portfolio | Commercial | Real Estate | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 17,150 | 18,802 | |||||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 3,597 | 3,710 | |||||
Acquired Loan Portfolio | Commercial | Construction | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 803 | 1,043 | |||||
Acquired Loan Portfolio | Consumer | Real Estate | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | 21,729 | 23,922 | |||||
Acquired Loan Portfolio | Consumer | Nonresidential | |||||||
Loans and Allowance for Loan Losses | |||||||
Loans, gross | $ 25 | $ 27 | |||||
|
Loans and Allowance for Loan Losses - Outstanding principal balance and related carrying amount of acquired loans (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
|
Loans and Allowance for Loan Losses | |||
Carrying amount | $ 16,229 | $ 19,029 | $ 18,911 |
Changes in the accretable yield on purchased credit impaired loans | |||
Balance at the beginning of the period | 3 | 216 | |
Accretion | (17) | (217) | |
Reclassification of nonaccretable difference due to changes in expected cash flows | 11 | 54 | |
Other changes, net | 3 | (50) | |
Balance at the end of the period | 0 | 3 | |
Purchased credit impaired | |||
Loans and Allowance for Loan Losses | |||
Outstanding principal balance | 194 | 207 | |
Carrying amount | 0 | 0 | |
Other acquired loans | |||
Loans and Allowance for Loan Losses | |||
Outstanding principal balance | 43,789 | 48,049 | |
Carrying amount | 43,304 | 47,504 | |
Acquired Loan Portfolio | |||
Loans and Allowance for Loan Losses | |||
Outstanding principal balance | 43,983 | 48,256 | |
Carrying amount | $ 43,304 | $ 47,504 |
Loans and Allowance for Loan Losses - Allowance for loan losses (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
|
Allowance for loan losses | |||
Loans and Leases Receivable, Allowance, Beginning Balance | $ 13,829 | $ 14,958 | $ 14,958 |
Charge-offs | (432) | (631) | (849) |
Recoveries | 16 | 94 | 220 |
Provision | 350 | 0 | (500) |
Loans and Leases Receivable, Allowance, Ending Balance | 13,763 | 14,421 | 13,829 |
Individually evaluated for impairment | 138 | 1,371 | 186 |
Collectively evaluated for impairment | 13,625 | 13,050 | 13,643 |
Total allowance for loans and leases receivables | 13,763 | 14,421 | 13,829 |
Loans receivables: | |||
Individually evaluated for impairment | 16,229 | 18,911 | 19,029 |
Collectively evaluated for impairment | 1,499,415 | 1,430,536 | 1,488,356 |
Loans receivable | 1,515,644 | 1,452,402 | 1,507,385 |
Purchased credit impaired | |||
Allowance for loan losses | |||
Purchased credit impaired | 0 | 0 | 0 |
Loans receivables: | |||
Individually evaluated for impairment | 0 | 0 | |
Purchased credit impaired | 0 | 2,955 | 0 |
Commercial | Real Estate | |||
Allowance for loan losses | |||
Loans and Leases Receivable, Allowance, Beginning Balance | 8,995 | 9,291 | 9,291 |
Charge-offs | 0 | (451) | (477) |
Recoveries | 0 | 24 | 24 |
Provision | 223 | 214 | 157 |
Loans and Leases Receivable, Allowance, Ending Balance | 9,218 | 9,078 | 8,995 |
Individually evaluated for impairment | 0 | 85 | 0 |
Collectively evaluated for impairment | 9,218 | 8,993 | 8,995 |
Total allowance for loans and leases receivables | 9,218 | 9,078 | 8,995 |
Loans receivables: | |||
Individually evaluated for impairment | 11,357 | 11,976 | 11,915 |
Collectively evaluated for impairment | 916,423 | 768,911 | 894,197 |
Loans receivable | 927,780 | 783,783 | 906,112 |
Commercial | Real Estate | Purchased credit impaired | |||
Allowance for loan losses | |||
Purchased credit impaired | 0 | 0 | 0 |
Loans receivables: | |||
Purchased credit impaired | 0 | 2,896 | 0 |
Commercial | Commercial and Industrial | |||
Allowance for loan losses | |||
Loans and Leases Receivable, Allowance, Beginning Balance | 1,827 | 2,546 | 2,546 |
Charge-offs | (396) | (117) | (117) |
Recoveries | 0 | 0 | 0 |
Provision | 556 | (116) | (602) |
Loans and Leases Receivable, Allowance, Ending Balance | 1,987 | 2,313 | 1,827 |
Individually evaluated for impairment | 135 | 1,263 | 181 |
Collectively evaluated for impairment | 1,852 | 1,050 | 1,646 |
Total allowance for loans and leases receivables | 1,987 | 2,313 | 1,827 |
Loans receivables: | |||
Individually evaluated for impairment | 4,676 | 6,466 | 5,214 |
Collectively evaluated for impairment | 194,002 | 270,155 | 197,536 |
Loans receivable | 198,678 | 276,621 | 202,750 |
Commercial | Commercial and Industrial | Purchased credit impaired | |||
Allowance for loan losses | |||
Purchased credit impaired | 0 | 0 | 0 |
Loans receivables: | |||
Purchased credit impaired | 0 | 0 | 0 |
Commercial | Construction | |||
Allowance for loan losses | |||
Loans and Leases Receivable, Allowance, Beginning Balance | 2,009 | 1,960 | 1,960 |
Charge-offs | 0 | 0 | 0 |
Recoveries | 0 | 0 | 0 |
Provision | (237) | 23 | 49 |
Loans and Leases Receivable, Allowance, Ending Balance | 1,772 | 1,983 | 2,009 |
Individually evaluated for impairment | 0 | 0 | 0 |
Collectively evaluated for impairment | 1,772 | 1,983 | 2,009 |
Total allowance for loans and leases receivables | 1,772 | 1,983 | 2,009 |
Loans receivables: | |||
Individually evaluated for impairment | 105 | 0 | 1,557 |
Collectively evaluated for impairment | 179,378 | 219,187 | 186,058 |
Loans receivable | 179,483 | 219,187 | 187,615 |
Commercial | Construction | Purchased credit impaired | |||
Allowance for loan losses | |||
Purchased credit impaired | 0 | 0 | 0 |
Loans receivables: | |||
Purchased credit impaired | 0 | 0 | 0 |
Consumer | Real Estate | |||
Allowance for loan losses | |||
Loans and Leases Receivable, Allowance, Beginning Balance | 781 | 690 | 690 |
Charge-offs | 0 | 0 | 0 |
Recoveries | 0 | 3 | 35 |
Provision | (171) | (41) | 56 |
Loans and Leases Receivable, Allowance, Ending Balance | 610 | 652 | 781 |
Individually evaluated for impairment | 3 | 23 | 5 |
Collectively evaluated for impairment | 607 | 629 | 776 |
Total allowance for loans and leases receivables | 610 | 652 | 781 |
Loans receivables: | |||
Individually evaluated for impairment | 91 | 469 | 343 |
Collectively evaluated for impairment | 202,761 | 158,689 | 200,261 |
Loans receivable | 202,852 | 159,217 | 200,604 |
Consumer | Real Estate | Purchased credit impaired | |||
Allowance for loan losses | |||
Purchased credit impaired | 0 | 0 | 0 |
Loans receivables: | |||
Purchased credit impaired | 0 | 59 | 0 |
Consumer | Nonresidential | |||
Allowance for loan losses | |||
Loans and Leases Receivable, Allowance, Beginning Balance | 217 | 471 | 471 |
Charge-offs | (36) | (63) | (255) |
Recoveries | 16 | 67 | 161 |
Provision | (21) | (80) | (160) |
Loans and Leases Receivable, Allowance, Ending Balance | 176 | 395 | 217 |
Individually evaluated for impairment | 0 | 0 | 0 |
Collectively evaluated for impairment | 176 | 395 | 217 |
Total allowance for loans and leases receivables | 176 | 395 | 217 |
Loans receivables: | |||
Individually evaluated for impairment | 0 | 0 | 0 |
Collectively evaluated for impairment | 6,851 | 13,594 | 10,304 |
Loans receivable | 6,851 | 13,594 | 10,304 |
Consumer | Nonresidential | Purchased credit impaired | |||
Allowance for loan losses | |||
Purchased credit impaired | 0 | 0 | 0 |
Loans receivables: | |||
Purchased credit impaired | $ 0 | $ 0 | $ 0 |
Loans and Allowance for Loan Losses - Impaired Loans (Details) - Originated Loan Portfolio - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
Recorded Investment | ||
With an allowance recorded | $ 1,769 | $ 1,771 |
With no related allowance | 14,460 | 17,258 |
Unpaid Principal Balance | ||
With an allowance recorded | 1,779 | 1,781 |
With no related allowance | 14,460 | 17,297 |
Related Allowance | 138 | 186 |
Average Recorded Investment | ||
With an allowance recorded | 1,780 | 1,806 |
With no related allowance | 14,978 | 17,454 |
Interest Income Recognized | ||
With an allowance recorded | 24 | 102 |
With no related allowance | 199 | 1,021 |
Commercial | Real Estate | ||
Recorded Investment | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 11,357 | 11,915 |
Unpaid Principal Balance | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 11,357 | 11,915 |
Related Allowance | 0 | 0 |
Average Recorded Investment | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 11,359 | 11,947 |
Interest Income Recognized | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 142 | 581 |
Commercial | Commercial and Industrial | ||
Recorded Investment | ||
With an allowance recorded | 1,678 | 1,678 |
With no related allowance | 2,998 | 3,536 |
Unpaid Principal Balance | ||
With an allowance recorded | 1,688 | 1,688 |
With no related allowance | 2,998 | 3,536 |
Related Allowance | 135 | 181 |
Average Recorded Investment | ||
With an allowance recorded | 1,688 | 1,711 |
With no related allowance | 3,415 | 3,660 |
Interest Income Recognized | ||
With an allowance recorded | 23 | 95 |
With no related allowance | 53 | 238 |
Commercial | Construction | ||
Recorded Investment | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 105 | 1,557 |
Unpaid Principal Balance | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 105 | 1,596 |
Related Allowance | 0 | 0 |
Average Recorded Investment | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 204 | 1,597 |
Interest Income Recognized | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 4 | 174 |
Consumer | Real Estate | ||
Recorded Investment | ||
With an allowance recorded | 91 | 93 |
With no related allowance | 0 | 250 |
Unpaid Principal Balance | ||
With an allowance recorded | 91 | 93 |
With no related allowance | 0 | 250 |
Related Allowance | 3 | 5 |
Average Recorded Investment | ||
With an allowance recorded | 92 | 95 |
With no related allowance | 0 | 250 |
Interest Income Recognized | ||
With an allowance recorded | 1 | 7 |
With no related allowance | 0 | 28 |
Consumer | Nonresidential | ||
Recorded Investment | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 0 | 0 |
Unpaid Principal Balance | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 0 | 0 |
Related Allowance | 0 | 0 |
Average Recorded Investment | ||
With an allowance recorded | 0 | 0 |
With no related allowance | 0 | 0 |
Interest Income Recognized | ||
With an allowance recorded | 0 | 0 |
With no related allowance | $ 0 | $ 0 |
Loans and Allowance for Loan Losses - Risk category (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
|
Loans and allowance - Risk category of loans | |||
Loans, gross | $ 1,515,644 | $ 1,507,385 | $ 1,452,402 |
Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 138 | ||
Commercial | Real Estate | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 927,780 | 906,112 | 783,783 |
Commercial | Commercial and Industrial | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 198,678 | 202,750 | 276,621 |
Commercial | Construction | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 179,483 | 187,615 | 219,187 |
Consumer | Real Estate | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 202,852 | 200,604 | 159,217 |
Consumer | Nonresidential | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 6,851 | 10,304 | $ 13,594 |
Originated Loan Portfolio | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 1,472,340 | 1,459,881 | |
Originated Loan Portfolio | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 1,452,774 | 1,437,866 | |
Originated Loan Portfolio | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 3,337 | 2,986 | |
Leases receivable | 3,000 | ||
Originated Loan Portfolio | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 16,229 | 19,029 | |
Decrease in related to loans | (2,800) | ||
Originated Loan Portfolio | Commercial | Real Estate | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 910,630 | 887,310 | |
Originated Loan Portfolio | Commercial | Real Estate | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 898,806 | 875,395 | |
Originated Loan Portfolio | Commercial | Real Estate | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 362 | 0 | |
Originated Loan Portfolio | Commercial | Real Estate | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 11,462 | 11,915 | |
Originated Loan Portfolio | Commercial | Commercial and Industrial | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 195,081 | 199,040 | |
Originated Loan Portfolio | Commercial | Commercial and Industrial | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 190,005 | 193,426 | |
Originated Loan Portfolio | Commercial | Commercial and Industrial | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 400 | 400 | |
Originated Loan Portfolio | Commercial | Commercial and Industrial | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 4,676 | 5,214 | |
Originated Loan Portfolio | Commercial | Construction | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 178,680 | 186,572 | |
Originated Loan Portfolio | Commercial | Construction | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 176,172 | 182,497 | |
Originated Loan Portfolio | Commercial | Construction | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 2,508 | 2,518 | |
Originated Loan Portfolio | Commercial | Construction | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 1,557 | |
Originated Loan Portfolio | Consumer | Real Estate | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 181,123 | 176,682 | |
Originated Loan Portfolio | Consumer | Real Estate | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 180,965 | 176,271 | |
Originated Loan Portfolio | Consumer | Real Estate | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 67 | 68 | |
Originated Loan Portfolio | Consumer | Real Estate | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 91 | 343 | |
Originated Loan Portfolio | Consumer | Nonresidential | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 6,826 | 10,277 | |
Originated Loan Portfolio | Consumer | Nonresidential | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 6,826 | 10,277 | |
Originated Loan Portfolio | Consumer | Nonresidential | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Originated Loan Portfolio | Consumer | Nonresidential | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 43,304 | 47,504 | |
Acquired Loan Portfolio | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 41,826 | 47,504 | |
Acquired Loan Portfolio | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 1,478 | 0 | |
Acquired Loan Portfolio | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Commercial | Real Estate | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 17,150 | 18,802 | |
Acquired Loan Portfolio | Commercial | Real Estate | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 15,672 | 18,802 | |
Acquired Loan Portfolio | Commercial | Real Estate | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 1,478 | 0 | |
Acquired Loan Portfolio | Commercial | Real Estate | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Commercial | Commercial and Industrial | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 3,597 | 3,710 | |
Acquired Loan Portfolio | Commercial | Commercial and Industrial | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 3,597 | 3,710 | |
Acquired Loan Portfolio | Commercial | Commercial and Industrial | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Commercial | Commercial and Industrial | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Commercial | Construction | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 803 | 1,043 | |
Acquired Loan Portfolio | Commercial | Construction | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 803 | 1,043 | |
Acquired Loan Portfolio | Commercial | Construction | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Commercial | Construction | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Consumer | Real Estate | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 21,729 | 23,922 | |
Acquired Loan Portfolio | Consumer | Real Estate | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 21,729 | 23,922 | |
Acquired Loan Portfolio | Consumer | Real Estate | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Consumer | Real Estate | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Consumer | Nonresidential | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 25 | 27 | |
Acquired Loan Portfolio | Consumer | Nonresidential | Pass | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 25 | 27 | |
Acquired Loan Portfolio | Consumer | Nonresidential | Special mention | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | 0 | |
Acquired Loan Portfolio | Consumer | Nonresidential | Substandard | |||
Loans and allowance - Risk category of loans | |||
Loans, gross | 0 | $ 0 | |
Original Loan Portfolio Discounted | Substandard | |||
Loans and allowance - Risk category of loans | |||
Decrease in related to loans | $ (1,800) |
Loans and Allowance for Loan Losses - Past due and Non accrual of loans (Details) - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Loans and Allowance for Loan Losses | |||||
Loans for which formal foreclosure proceedings are in process | $ 0 | $ 0 | |||
Loans, net | 1,498,712,000 | 1,490,020,000 | [1] | ||
Federal Home Loan Bank of Atlanta | |||||
Loans and Allowance for Loan Losses | |||||
Loans pledged | 265,600,000 | 290,300,000 | |||
Adjustment | |||||
Loans and Allowance for Loan Losses | |||||
Loans, net | 56,000 | 58,000 | |||
Originated Loan Portfolio | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 1,472,340,000 | 1,459,881,000 | |||
90 days past due and still accruing | 0 | 18,000 | |||
Nonaccruals | 3,486,000 | 3,485,000 | |||
Loans, net | 1,455,408,000 | 1,442,516,000 | |||
Originated Loan Portfolio | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 4,289,000 | 14,000 | |||
Originated Loan Portfolio | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 21,000 | |||
Originated Loan Portfolio | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 3,486,000 | 3,503,000 | |||
Originated Loan Portfolio | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 7,775,000 | 3,538,000 | |||
Originated Loan Portfolio | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 1,464,565,000 | 1,456,343,000 | |||
Originated Loan Portfolio | Commercial | Real Estate | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 910,630,000 | 887,310,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 1,808,000 | 0 | |||
Originated Loan Portfolio | Commercial | Real Estate | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Originated Loan Portfolio | Commercial | Real Estate | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Originated Loan Portfolio | Commercial | Real Estate | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 1,808,000 | 0 | |||
Originated Loan Portfolio | Commercial | Real Estate | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 1,808,000 | 0 | |||
Originated Loan Portfolio | Commercial | Real Estate | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 908,822,000 | 887,310,000 | |||
Originated Loan Portfolio | Commercial | Commercial and Industrial | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 195,081,000 | 199,040,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 1,678,000 | 1,678,000 | |||
Originated Loan Portfolio | Commercial | Commercial and Industrial | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 1,261,000 | 0 | |||
Originated Loan Portfolio | Commercial | Commercial and Industrial | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Originated Loan Portfolio | Commercial | Commercial and Industrial | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 1,678,000 | 1,678,000 | |||
Originated Loan Portfolio | Commercial | Commercial and Industrial | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 2,939,000 | 1,678,000 | |||
Originated Loan Portfolio | Commercial | Commercial and Industrial | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 192,142,000 | 197,362,000 | |||
Originated Loan Portfolio | Commercial | Construction | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 178,680,000 | 186,572,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 0 | 1,557,000 | |||
Originated Loan Portfolio | Commercial | Construction | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 2,944,000 | 0 | |||
Originated Loan Portfolio | Commercial | Construction | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Originated Loan Portfolio | Commercial | Construction | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 1,557,000 | |||
Originated Loan Portfolio | Commercial | Construction | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 2,944,000 | 1,557,000 | |||
Originated Loan Portfolio | Commercial | Construction | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 175,736,000 | 185,015,000 | |||
Originated Loan Portfolio | Consumer | Real Estate | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 181,123,000 | 176,682,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 0 | 250,000 | |||
Originated Loan Portfolio | Consumer | Real Estate | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 67,000 | 0 | |||
Originated Loan Portfolio | Consumer | Real Estate | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Originated Loan Portfolio | Consumer | Real Estate | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 250,000 | |||
Originated Loan Portfolio | Consumer | Real Estate | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 67,000 | 250,000 | |||
Originated Loan Portfolio | Consumer | Real Estate | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 181,056,000 | 176,432,000 | |||
Originated Loan Portfolio | Consumer | Nonresidential | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 6,826,000 | 10,277,000 | |||
90 days past due and still accruing | 0 | 18,000 | |||
Nonaccruals | 0 | 0 | |||
Originated Loan Portfolio | Consumer | Nonresidential | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 17,000 | 14,000 | |||
Originated Loan Portfolio | Consumer | Nonresidential | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 21,000 | |||
Originated Loan Portfolio | Consumer | Nonresidential | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 18,000 | |||
Originated Loan Portfolio | Consumer | Nonresidential | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 17,000 | 53,000 | |||
Originated Loan Portfolio | Consumer | Nonresidential | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 6,809,000 | 10,224,000 | |||
Acquired Loan Portfolio | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 43,304,000 | 47,504,000 | |||
90 days past due and still accruing | 0 | 5,000 | |||
Nonaccruals | 0 | 0 | |||
Loans, net | 43,304,000 | 47,504,000 | |||
Acquired Loan Portfolio | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 236,000 | |||
Acquired Loan Portfolio | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 5,000 | |||
Acquired Loan Portfolio | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 241,000 | |||
Acquired Loan Portfolio | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 43,304,000 | 47,263,000 | |||
Acquired Loan Portfolio | Commercial | Real Estate | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 17,150,000 | 18,802,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Real Estate | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Real Estate | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Real Estate | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Real Estate | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Real Estate | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 17,150,000 | 18,802,000 | |||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 3,597,000 | 3,710,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Commercial and Industrial | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 3,597,000 | 3,710,000 | |||
Acquired Loan Portfolio | Commercial | Construction | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 803,000 | 1,043,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Construction | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Construction | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Construction | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Construction | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Commercial | Construction | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 803,000 | 1,043,000 | |||
Acquired Loan Portfolio | Consumer | Real Estate | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 21,729,000 | 23,922,000 | |||
90 days past due and still accruing | 0 | 5,000 | |||
Nonaccruals | 0 | 0 | |||
Acquired Loan Portfolio | Consumer | Real Estate | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 234,000 | |||
Acquired Loan Portfolio | Consumer | Real Estate | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Consumer | Real Estate | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 5,000 | |||
Acquired Loan Portfolio | Consumer | Real Estate | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 239,000 | |||
Acquired Loan Portfolio | Consumer | Real Estate | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 21,729,000 | 23,683,000 | |||
Acquired Loan Portfolio | Consumer | Nonresidential | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 25,000 | 27,000 | |||
90 days past due and still accruing | 0 | 0 | |||
Nonaccruals | 0 | 0 | |||
Acquired Loan Portfolio | Consumer | Nonresidential | 30-59 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 2,000 | |||
Acquired Loan Portfolio | Consumer | Nonresidential | 60-89 days past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Consumer | Nonresidential | 90 days or more past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 0 | |||
Acquired Loan Portfolio | Consumer | Nonresidential | Total past due | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | 0 | 2,000 | |||
Acquired Loan Portfolio | Consumer | Nonresidential | Current | |||||
Loans and Allowance for Loan Losses | |||||
Financing receivables | $ 25,000 | $ 25,000 | |||
|
Loans and Allowance for Loan Losses - Troubled debt restructurings (Details) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2021
USD ($)
contract
|
Mar. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
|
Loans and Allowance for Loan Losses - Troubled debt restructurings | |||
Number of Contracts | contract | 1 | ||
Pre-Modification Outstanding Recorded Investment | $ 96 | ||
Post-Modification Outstanding Recorded Investment | $ 96 | ||
Recorded investment in troubled debt restructurings | $ 91 | $ 92 | |
Consumer | Real Estate | |||
Loans and Allowance for Loan Losses - Troubled debt restructurings | |||
Number of Contracts | contract | 1 | ||
Pre-Modification Outstanding Recorded Investment | $ 96 | ||
Post-Modification Outstanding Recorded Investment | $ 96 |
Derivative Financial Instruments (Details) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2022
USD ($)
agreement
|
Dec. 31, 2021
USD ($)
agreement
|
|
Interest rate swap | ||
Derivative Financial Instruments | ||
Number of swap agreements outstanding not included in the offsetting | agreement | 14 | 19 |
Collateralized amount | $ 400 | $ 6,700 |
Receive Fixed/Pay Variable Swaps | ||
Derivative Financial Instruments | ||
Notional Amount | 80,338 | 80,643 |
Derivative liability, Fair Value | 1,181 | 6,052 |
Pay Fixed/Receive Variable Swaps | ||
Derivative Financial Instruments | ||
Notional Amount | 80,338 | 80,643 |
Derivative asset, Fair Value | $ (1,181) | $ (6,052) |
Derivative Financial Instruments - Interest Rate Risk Management-Cash Flow Hedging Instruments (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
|
Derivative Financial Instruments | |||
Unrealized gain (loss) relating to interest rate swaps | $ 643 | $ 198 | |
Cash flow hedge | |||
Derivative Financial Instruments | |||
Notional amount | $ 60,000 | $ 60,000 | |
Weighted average pay rate | 0.87% | 0.87% | |
Weighted average receive rate | 0.84% | 0.21% | |
Weighted average maturity in years | 10 months 6 days | 1 year 1 month 6 days | |
Unrealized gain (loss) relating to interest rate swaps | $ 566 | $ (77) |
Financial Instruments with Off-Balance Sheet Risk (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
Financial Instruments with Off-Balance Sheet Risk | ||
Cash on deposit in correspondent banks exceeding the federally insured limits | $ 16,000 | $ 32,800 |
Commitments to grant loans | Contract credit risk | ||
Financial Instruments with Off-Balance Sheet Risk | ||
Financial instruments outstanding | 100,631 | 90,591 |
Unused commitments to fund loans and lines of credit | Contract credit risk | ||
Financial Instruments with Off-Balance Sheet Risk | ||
Financial instruments outstanding | 185,543 | 183,145 |
Commercial and standby letters of credit | Contract credit risk | ||
Financial Instruments with Off-Balance Sheet Risk | ||
Financial instruments outstanding | $ 9,294 | 8,930 |
Letters of credit expiration period (in years) | 1 year | |
Interest rate lock commitments | Contract credit risk | ||
Financial Instruments with Off-Balance Sheet Risk | ||
Financial instruments outstanding | $ 92,776 | $ 0 |
Stock-Based Compensation Plan (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Stock-Based Compensation Plan | ||
Number of shares withheld to cover the cost of the exercise | 4,772 | 0 |
Stock option | ||
Stock-Based Compensation Plan | ||
Total income tax benefits related to stock options exercised | $ 204 | $ 125 |
Compensation cost | 204 | $ 166 |
Restricted stock | ||
Stock-Based Compensation Plan | ||
Unamortized compensation cost | $ 1,900 | |
Period for recognition for cost not yet recognized | 28 months | |
Amended and Restated 2008 Option Plan | Stock option | ||
Stock-Based Compensation Plan | ||
Additional shares authorized for issuance (in shares) | 200,000 | |
Maximum shares authorized (in shares) | 2,529,296 | |
Vesting period (in years) | 4 years | |
Contractual term (in years) | 10 years | |
Shares available for grant (in shares) | 47,392 | |
Options granted (in shares) | 0 | 0 |
Amended and Restated 2008 Option Plan | Restricted stock | ||
Stock-Based Compensation Plan | ||
Granted (in shares) | 3,000 | 116,488 |
Stock-Based Compensation Plan - Options (Details) - Amended and Restated 2008 Option Plan - Stock option - USD ($) |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
|
Number of Shares | |||
Outstanding at the beginning of the year (in shares) | 1,544,893 | ||
Granted (in shares) | 0 | 0 | |
Exercised (in shares) | (216,492) | ||
Forfeited or expired (in shares) | (97) | ||
Outstanding at the end of the year (in shares) | 1,328,304 | 1,544,893 | |
Exercisable at the end of the year (in shares) | 1,328,304 | ||
Weighted- Average Exercise Price | |||
Outstanding at the beginning of the year (in dollars per share) | $ 8.31 | ||
Granted (in dollars per share) | 0 | ||
Exercised (in dollars per share) | 7.07 | ||
Forfeited or expired (in dollars per share) | 8.56 | ||
Outstanding at the end of the year (in dollars per share) | 8.51 | $ 8.31 | |
Exercisable at the end of the year (in dollars per share) | $ 8.51 | ||
Additional disclosures | |||
Outstanding Weighted-Average Remaining Contractual Term (in years) | 2 years 5 months 15 days | ||
Exercisable Weighted-Average Remaining Contractual Term (in years) | 2 years 6 months 18 days | ||
Exercisable Aggregate Intrinsic Value | $ 16,280,460 |
Stock-Based Compensation Plan - Restricted stock (Details) - Amended and Restated 2008 Option Plan - Restricted stock - $ / shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Number of Shares | ||
Balance at the beginning of the year (in shares) | 151,403 | |
Granted (in shares) | 3,000 | 116,488 |
Vested (in shares) | (28,244) | |
Forfeited (in shares) | (2,363) | |
Balance at the end of the year (in shares) | 123,796 | |
Weighted Average Grant Date Fair Value | ||
Outstanding at the beginning of the year (in dollars per share) | $ 17.92 | |
Granted (in dollars per share) | 20.83 | |
Vested (in dollars per share) | 17.49 | |
Forfeited (in dollars per share) | 18.63 | |
Outstanding at the end of the year (in dollars per share) | $ 18.08 |
Fair Value Measurements - Financial assets and liabilities measured at fair value on a recurring basis (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Assets | |||||
Securities available-for-sale, at fair value | $ 330,337 | $ 357,774 | [1] | ||
Securities of U.S. government and federal agencies | |||||
Assets | |||||
Securities available-for-sale, at fair value | 12,335 | 13,436 | |||
Corporate bonds | |||||
Assets | |||||
Securities available-for-sale, at fair value | 19,881 | 14,151 | |||
SBA pass-through securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 88 | 108 | |||
Mortgage-backed securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 284,270 | 313,838 | |||
Collateralized mortgage obligations | |||||
Assets | |||||
Securities available-for-sale, at fair value | 11,815 | 14,194 | |||
Level 1 | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Level 2 | |||||
Assets | |||||
Securities available-for-sale, at fair value | 330,337 | 357,774 | |||
Level 3 | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | |||||
Assets | |||||
Securities available-for-sale, at fair value | 330,337 | 357,774 | |||
Recurring | Securities of U.S. government and federal agencies | |||||
Assets | |||||
Securities available-for-sale, at fair value | 12,335 | 13,436 | |||
Recurring | Securities of state and local municipalities tax exempt | |||||
Assets | |||||
Securities available-for-sale, at fair value | 1,399 | 1,451 | |||
Recurring | Securities of state and local municipalities taxable | |||||
Assets | |||||
Securities available-for-sale, at fair value | 549 | 596 | |||
Recurring | Corporate bonds | |||||
Assets | |||||
Securities available-for-sale, at fair value | 19,881 | 14,151 | |||
Recurring | SBA pass-through securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 88 | 108 | |||
Recurring | Mortgage-backed securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 284,270 | 313,838 | |||
Recurring | Collateralized mortgage obligations | |||||
Assets | |||||
Securities available-for-sale, at fair value | 11,815 | 14,194 | |||
Recurring | Level 1 | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | Securities of U.S. government and federal agencies | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | Securities of state and local municipalities tax exempt | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | Securities of state and local municipalities taxable | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | Corporate bonds | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | SBA pass-through securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | Mortgage-backed securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 1 | Collateralized mortgage obligations | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 2 | |||||
Assets | |||||
Securities available-for-sale, at fair value | 330,337 | 357,774 | |||
Recurring | Level 2 | Securities of U.S. government and federal agencies | |||||
Assets | |||||
Securities available-for-sale, at fair value | 12,335 | 13,436 | |||
Recurring | Level 2 | Securities of state and local municipalities tax exempt | |||||
Assets | |||||
Securities available-for-sale, at fair value | 1,399 | 1,451 | |||
Recurring | Level 2 | Securities of state and local municipalities taxable | |||||
Assets | |||||
Securities available-for-sale, at fair value | 549 | 596 | |||
Recurring | Level 2 | Corporate bonds | |||||
Assets | |||||
Securities available-for-sale, at fair value | 19,881 | 14,151 | |||
Recurring | Level 2 | SBA pass-through securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 88 | 108 | |||
Recurring | Level 2 | Mortgage-backed securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 284,270 | 313,838 | |||
Recurring | Level 2 | Collateralized mortgage obligations | |||||
Assets | |||||
Securities available-for-sale, at fair value | 11,815 | 14,194 | |||
Recurring | Level 3 | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | Securities of U.S. government and federal agencies | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | Securities of state and local municipalities tax exempt | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | Securities of state and local municipalities taxable | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | Corporate bonds | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | SBA pass-through securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | Mortgage-backed securities | |||||
Assets | |||||
Securities available-for-sale, at fair value | 0 | 0 | |||
Recurring | Level 3 | Collateralized mortgage obligations | |||||
Assets | |||||
Securities available-for-sale, at fair value | $ 0 | $ 0 | |||
|
Fair Value Measurements - Assets measured at fair value on a nonrecurring basis (Details) - Nonrecurring - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
---|---|---|
Assets | ||
Impaired loans | $ 1,631 | $ 1,585 |
Commercial and Industrial | ||
Assets | ||
Impaired loans | 1,543 | 1,497 |
Residential Real Estate | ||
Assets | ||
Impaired loans | 88 | 88 |
Level 1 | ||
Assets | ||
Impaired loans | 0 | 0 |
Level 1 | Commercial and Industrial | ||
Assets | ||
Impaired loans | 0 | 0 |
Level 1 | Residential Real Estate | ||
Assets | ||
Impaired loans | 0 | 0 |
Level 2 | ||
Assets | ||
Impaired loans | 0 | 0 |
Level 2 | Commercial and Industrial | ||
Assets | ||
Impaired loans | 0 | 0 |
Level 2 | Residential Real Estate | ||
Assets | ||
Impaired loans | 0 | 0 |
Level 3 | ||
Assets | ||
Impaired loans | 1,631 | 1,585 |
Level 3 | Commercial and Industrial | ||
Assets | ||
Impaired loans | 1,543 | 1,497 |
Level 3 | Residential Real Estate | ||
Assets | ||
Impaired loans | $ 88 | $ 88 |
Fair Value Measurements - Quantitative information about Level 3 fair value measurements (Details) $ in Thousands |
Mar. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
---|---|---|
Nonrecurring | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans | $ 1,631 | $ 1,585 |
Nonrecurring | Commercial and Industrial | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans | 1,543 | 1,497 |
Nonrecurring | Residential Real Estate | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans | $ 88 | $ 88 |
Level 3 | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Valuation Technique | Valuation Technique Discounted Appraised Value [Member] | Valuation Technique Discounted Appraised Value [Member] |
Impaired loans, Measurement Input | Measurement Input, Cost to Sell [Member] | Measurement Input, Cost to Sell [Member] |
Level 3 | Minimum | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.08 | 0.08 |
Level 3 | Minimum | Commercial and Industrial | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.08 | 0.08 |
Level 3 | Minimum | Residential Real Estate | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.08 | 0.08 |
Level 3 | Maximum | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.08 | 0.08 |
Level 3 | Maximum | Commercial and Industrial | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.08 | 0.08 |
Level 3 | Maximum | Residential Real Estate | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.08 | 0.08 |
Level 3 | Avg | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.0800 | 0.0800 |
Level 3 | Avg | Commercial and Industrial | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.0800 | 0.0800 |
Level 3 | Avg | Residential Real Estate | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans, Range | 0.0800 | 0.0800 |
Level 3 | Nonrecurring | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans | $ 1,631 | $ 1,585 |
Level 3 | Nonrecurring | Commercial and Industrial | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans | 1,543 | 1,497 |
Level 3 | Nonrecurring | Residential Real Estate | ||
Quantitative information about Level 3 Fair Value Measurements | ||
Impaired loans | $ 88 | $ 88 |
Fair Value Measurements - Carrying amount, fair value and placement in the fair value hierarchy of financial instruments (Details) - USD ($) $ in Thousands |
Mar. 31, 2022 |
Dec. 31, 2021 |
|||
---|---|---|---|---|---|
Financial assets: | |||||
Cash and due from banks | $ 16,869 | $ 24,613 | [1] | ||
Interest-bearing deposits at other institutions | 122,117 | 216,345 | [1] | ||
Securities available-for-sale | 330,337 | 357,774 | [1] | ||
Restricted stock | 6,262 | 6,372 | [1] | ||
Loans, net | 1,498,712 | 1,490,020 | [1] | ||
Bank owned life insurance | 39,409 | 39,171 | [1] | ||
Accrued interest receivable | 8,089 | 8,074 | [1] | ||
Financial liabilities: | |||||
Time deposits | 211,574 | 231,417 | [1] | ||
Subordinated notes | 19,524 | 19,510 | [1] | ||
Accrued interest payable | 1,131 | 1,034 | [1] | ||
Carrying Amount | |||||
Financial assets: | |||||
Cash and due from banks | 16,869 | 24,613 | |||
Interest-bearing deposits at other institutions | 122,117 | 216,345 | |||
Securities held-to-maturity | 264 | 264 | |||
Securities available-for-sale | 330,337 | 357,774 | |||
Restricted stock | 6,262 | 6,372 | |||
Loans, net | 1,498,712 | 1,490,020 | |||
Bank owned life insurance | 39,409 | 39,171 | |||
Accrued interest receivable | 8,089 | 8,074 | |||
Financial liabilities: | |||||
Checking, savings and money market accounts | 1,607,781 | 1,652,352 | |||
Time deposits | 211,574 | 231,417 | |||
FHLB advances | 25,000 | 25,000 | |||
Subordinated notes | 19,524 | 19,510 | |||
Accrued interest payable | 1,131 | 1,034 | |||
Cash flow hedge | Carrying Amount | |||||
Financial assets: | |||||
Derivative assets | 611 | ||||
Financial liabilities: | |||||
Derivative liabilities | 45 | 77 | |||
Interest rate swap | Carrying Amount | |||||
Financial assets: | |||||
Derivative assets | 1,181 | 6,052 | |||
Financial liabilities: | |||||
Derivative liabilities | 1,181 | 6,052 | |||
Level 1 | |||||
Financial assets: | |||||
Cash and due from banks | 16,869 | 24,613 | |||
Interest-bearing deposits at other institutions | 122,117 | 216,345 | |||
Securities held-to-maturity | 0 | 0 | |||
Securities available-for-sale | 0 | 0 | |||
Restricted stock | 0 | 0 | |||
Loans, net | 0 | 0 | |||
Bank owned life insurance | 0 | 0 | |||
Accrued interest receivable | 0 | 0 | |||
Financial liabilities: | |||||
Checking, savings and money market accounts | 0 | 0 | |||
Time deposits | 0 | 0 | |||
FHLB advances | 0 | 0 | |||
Subordinated notes | 0 | 0 | |||
Accrued interest payable | 0 | 0 | |||
Level 1 | Cash flow hedge | |||||
Financial assets: | |||||
Derivative assets | 0 | ||||
Financial liabilities: | |||||
Derivative liabilities | 0 | 0 | |||
Level 1 | Interest rate swap | |||||
Financial assets: | |||||
Derivative assets | 0 | 0 | |||
Financial liabilities: | |||||
Derivative liabilities | 0 | 0 | |||
Level 2 | |||||
Financial assets: | |||||
Cash and due from banks | 0 | 0 | |||
Interest-bearing deposits at other institutions | 0 | 0 | |||
Securities held-to-maturity | 265 | 270 | |||
Securities available-for-sale | 330,337 | 357,774 | |||
Restricted stock | 6,262 | 6,372 | |||
Loans, net | 0 | 0 | |||
Bank owned life insurance | 39,409 | 39,171 | |||
Accrued interest receivable | 8,089 | 8,074 | |||
Financial liabilities: | |||||
Checking, savings and money market accounts | 1,607,781 | 1,652,352 | |||
Time deposits | 212,638 | 232,837 | |||
FHLB advances | 25,000 | 25,000 | |||
Subordinated notes | 17,905 | 18,133 | |||
Accrued interest payable | 1,131 | 1,034 | |||
Level 2 | Cash flow hedge | |||||
Financial assets: | |||||
Derivative assets | 611 | ||||
Financial liabilities: | |||||
Derivative liabilities | 45 | 77 | |||
Level 2 | Interest rate swap | |||||
Financial assets: | |||||
Derivative assets | 1,181 | 6,052 | |||
Financial liabilities: | |||||
Derivative liabilities | 1,181 | 6,052 | |||
Level 3 | |||||
Financial assets: | |||||
Cash and due from banks | 0 | 0 | |||
Interest-bearing deposits at other institutions | 0 | 0 | |||
Securities held-to-maturity | 0 | 0 | |||
Securities available-for-sale | 0 | 0 | |||
Restricted stock | 0 | 0 | |||
Loans, net | 1,451,864 | 1,493,185 | |||
Bank owned life insurance | 0 | 0 | |||
Accrued interest receivable | 0 | 0 | |||
Financial liabilities: | |||||
Checking, savings and money market accounts | 0 | 0 | |||
Time deposits | 0 | 0 | |||
FHLB advances | 0 | 0 | |||
Subordinated notes | 0 | 0 | |||
Accrued interest payable | 0 | 0 | |||
Level 3 | Cash flow hedge | |||||
Financial assets: | |||||
Derivative assets | 0 | ||||
Financial liabilities: | |||||
Derivative liabilities | 0 | 0 | |||
Level 3 | Interest rate swap | |||||
Financial assets: | |||||
Derivative assets | 0 | 0 | |||
Financial liabilities: | |||||
Derivative liabilities | $ 0 | $ 0 | |||
|
Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Earnings Per Share [Abstract] | ||
Number of anti-dilutive shares excluded from the calculation (in shares) | 0 | 0 |
Net income | $ 6,613 | $ 5,569 |
Weighted average number of shares (in shares) | 13,833 | 13,578 |
Effect of dilutive securities, restricted stock units and options (in shares) | 881 | 958 |
Weighted average diluted shares (in shares) | 14,714 | 14,536 |
Basic EPS (in dollars per share) | $ 0.48 | $ 0.41 |
Diluted EPS (in dollars per share) | $ 0.45 | $ 0.38 |
Accumulated Other Comprehensive Income (Loss) (Details) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022
USD ($)
component
|
Mar. 31, 2021
USD ($)
component
|
|
Changes in accumulated other comprehensive income | ||
Balance, beginning of period | $ (2,043) | $ 1,826 |
Net unrealized (losses) gains during the period | (17,171) | (1,125) |
Other comprehensive (loss) income, net of tax | (17,171) | (1,125) |
Balance, end of period | $ (19,214) | $ 701 |
Accumulated Other Comprehensive Income | ||
Number of securities component of AOCI | component | 2 | 2 |
Changes in accumulated other comprehensive income | ||
Other comprehensive (loss) income, net of tax | $ (17,171) | $ (1,125) |
Available-for-Sale Securities | ||
Changes in accumulated other comprehensive income | ||
Balance, beginning of period | (1,983) | 2,421 |
Net unrealized (losses) gains during the period | (17,679) | (1,281) |
Other comprehensive (loss) income, net of tax | (17,679) | (1,281) |
Balance, end of period | (19,662) | 1,140 |
Cash Flow Hedges | ||
Changes in accumulated other comprehensive income | ||
Balance, beginning of period | (60) | (595) |
Net unrealized (losses) gains during the period | 508 | 156 |
Other comprehensive (loss) income, net of tax | 508 | 156 |
Balance, end of period | $ 448 | $ (439) |
Subordinated Notes (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Oct. 13, 2020 |
Feb. 28, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Jun. 20, 2016 |
|
Subordinated Notes | |||||
Subordinated Notes | |||||
Face amount | $ 25.0 | ||||
Interest rate | 6.00% | ||||
Redemption price percentage of outstanding principal amount | 100.00% | ||||
Principal amount redeemed | $ 1.2 | $ 23.8 | |||
Subordinated Notes | LIBOR | |||||
Subordinated Notes | |||||
Variable interest rate (as a percent) | 4.87% | ||||
Subordinated Notes due 2030 | |||||
Subordinated Notes | |||||
Face amount | $ 20.0 | ||||
Interest rate | 4.875% | ||||
Term for fixed interest rate | 5 years | ||||
Subordinated Notes due 2030 | 3-month SOFR | |||||
Subordinated Notes | |||||
Variable interest rate (as a percent) | 4.71% | ||||
Minimum | Subordinated Notes | |||||
Subordinated Notes | |||||
Notice period for redeem the subordinated notes | 30 days | ||||
Maximum | Subordinated Notes | |||||
Subordinated Notes | |||||
Notice period for redeem the subordinated notes | 60 days |
Revenue Recognition (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Revenue Recognition | ||
Total noninterest income | $ 1,624 | $ 791 |
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract | true | |
Before adoption of ASU 2014-09 | ||
Revenue Recognition | ||
Noninterest Income (in-scope of Topic 606) | $ 390 | 481 |
Noninterest Income (out-scope of Topic 606) | 1,234 | 310 |
Total noninterest income | 1,624 | 791 |
Other income | Before adoption of ASU 2014-09 | ||
Revenue Recognition | ||
Noninterest Income (in-scope of Topic 606) | 65 | 160 |
Service Charges on Deposit Accounts | Before adoption of ASU 2014-09 | ||
Revenue Recognition | ||
Noninterest Income (in-scope of Topic 606) | 234 | 243 |
Fees, Exchange, and Other Service Charges | Before adoption of ASU 2014-09 | ||
Revenue Recognition | ||
Noninterest Income (in-scope of Topic 606) | $ 91 | $ 78 |
Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Supplemental Disclosure of Cash Flow Information: | ||
Interest on deposits and borrowed funds | $ 2,072 | $ 2,048 |
Income taxes | 0 | 0 |
Noncash investing and financing activities: | ||
Unrealized (loss) gain on securities available-for-sale | (22,379) | (1,577) |
Unrealized gain (loss) on interest rate swaps | $ 643 | $ 198 |
#68N'.@%Z+VR>_]TY9)^OMJ'\?TTUWQ,=;SZI".P]N
MXR W2TWU-6QW6T.[#N]X9_^&C:[VI5>:VB7YDLVE=J!PQI3)^27+LK7SU LR
MB_!XIX;8"L*T9+-&ZP/X_\P8VBQ\@M;^A_\ 4$L#!!0 ( (=IK%0XQ86=
M+@< (@< 8 >&PO=V]R:W-H965T)'35CR?0\N4]-?(O=%%2YMT'GS<>#"6_2=QR>$RW-B%M,2D#]R5&G![3%K49!3U=<^#]'XM
M52J*DB-3OH94IO6>%0FOW,F+GK@!$/:QNS(4#X!O^0?34? KJ3B W$EP%&M?
M5CR*-63@;EAX 5,'C.LEKDP\9.V6R? XE3T8F3Q-;2F6@CESJ$]U97G^P[:]
M!%\KA".H@&X+@MO3/Q8&!]YW9)+MC(CTN:H5,FBU7-52O,5U.FU)*%WUKNF(1"88BJ:4_
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MD[2,2\89]U4&*K=E1Q;EL//96,J4MF=)Q,BUC
MJUM3M;%5R*+/J6!!?\YD/3:+#3T6
MF"KT)Z)X%BHCF,:0#WT,6J)T]A0E !@*[KM!O5+B6A]QD@W([FAW8>W2](GY
MZ^0&CPP]\_Y'P$_2Q1S>O)\?C1!PJ+ZU3^E<+$'<(#I!>Q%%BX5R;[@F1'$.
MZ$H[JN$1!=SJJ%5;2%(03O%D*
@;,04#EQ7[/6">#
I K"$%-4O(0J1,_B//QX.CH'"^3P>1\(H@F4#>\6QR1
MOL_D!WML^__J?GI\A)?3P?AD^EVZ$WV?R;?W?Z39Y;X=E3CNTX^?D#7B%D%J
M1]#7!K<:S47Y*923T"2K0U9GUI3"XQA%8,E/Y /:
MC:EMPCE(A*&W0?)K$T:A8HU45+G 3,^U+]=C\EJ'N:H8'VIIR;J,E:K='
M1T;/.-HU9O)8FN"8Z0)8=(J8IS^V(B!K4TGZ C-!&;V6P#_3?C;
M@+[W< \?,;EVV8,*P4M['>(,L,(WN+0OC,]-GC);FS]]!/^5_#F("<0=T^EY
MG!YXAJ>0SPWWB=R:>A[V1&>J+86 :- 5_'=!U2":%6X9>)!2UJ/!LGBS =1O
MNZYV83#(44=OYL1F#:T[S>Z<.S,6ASNLA%HQH49>G[H/0IWX;JZGBJ=I[+M_
M)V\\:J:E^HX]EM)M8'O_,W4G/M-UT6_+^V\ :6Q3@+GQ8#P>KU]^Y:L-&J4P
M_P&WJ'R"\\?#\S/QU^:Q0V
*%TL06@0^Y,O6-#5$^+I*(HG_>K5]O@*' (8TZ[.73M*X,"9
M7#JW&@RBZ6!L_9PXOE@)XW]A5\6.3@.(2V-57H-)0
ZY?7LB@Q5\= RF,K2W4H98/!(=>?VY6